nimodipine has been researched along with Angiospasm, Intracranial in 189 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results are consistent with a beneficial effect of locally delivered nimodipine (EG-1962) on SD after aSAH in more severely injured patients who are at risk of delayed cerebral ischemia related to SD." | 9.41 | Effect of Locally Delivered Nimodipine Microparticles on Spreading Depolarization in Aneurysmal Subarachnoid Hemorrhage. ( Alchbli, A; Carlson, AP; Hänggi, D; Macdonald, RL; Shuttleworth, CW, 2021) |
| "Our objective was to compare the effectiveness of intravenous and enteral nimodipine in preventing poor outcome from delayed cerebral ischemia in patients with subarachnoid hemorrhage." | 9.22 | A Comparison Between Enteral and Intravenous Nimodipine in Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis. ( Boscolo, A; Cacco, N; Carere, A; Correale, C; De Cassai, A; Diana, P; Disarò, L; Geraldini, F; Munari, M; Navalesi, P; Zampirollo, S, 2022) |
| "Fasudil is believed to be at least equally effective as nimodipine for the prevention of cerebral vasospasm and subsequent ischemic injury in patients undergoing surgery for subarachnoid hemorrhage (SAH)." | 9.15 | Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. ( Guo, J; Mao, Y; Ren, Z; Wang, R; Wang, S; Xu, B; Zhang, X; Zhang, Y; Zhao, J; Zhao, K; Zhou, D; Zhou, L, 2011) |
| "The calcium antagonist nimodipine has been shown to reduce the incidence of ischemic complications following aneurysmal subarachnoid hemorrhage (SAH)." | 9.14 | Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. ( Cronqvist, M; Kronvall, E; Nilsson, OG; Romner, B; Säveland, H; Undrén, P, 2009) |
| "The efficacy of intra-arterial administration of nimodipine (IAN) in patients with severe vasospasm after aneurysmal subarachnoid hemorrhage (SAH) remains unproved." | 9.13 | Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion. ( Beseoglu, K; Hänggi, D; Steiger, HJ; Turowski, B; Yong, M, 2008) |
| "The prophylactic use of nimodipine in patients with aneurysmal subarachnoid hemorrhage reduces the risk of ischemic brain damage." | 9.12 | Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. ( Briegel, J; Kunz, M; Prueckner, S; Schmid-Elsaesser, R; Steiger, HJ; Zausinger, S, 2006) |
| " This randomized open trial with nimodipine as the control included 72 patients who underwent subarachnoid hemorrhage surgery for ruptured cerebral aneurysm of Hunt and Hess grades I to IV." | 9.12 | Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. ( Guo, J; Ren, Z; Wang, R; Wang, S; Xu, B; Zhao, J; Zhou, D; Zhou, L, 2006) |
| "Eleven patients with primary thunderclap headache (TCH) were treated with oral nimodipine 30 to 60 mg every 4 hours or IV nimodipine 0." | 9.11 | Nimodipine for treatment of primary thunderclap headache. ( Fuh, JL; Liao, YC; Lirng, JF; Lu, SR; Wang, SJ, 2004) |
| "Thirty consecutive patients under-going intracranial aneurysmal surgery were prospectively randomized into two groups: Isoflurane (group A, n = 15) and nimodipine (group B, n = 15)." | 9.11 | [The effect of intraoperative continuous nimodipine infusion on cerebral vasospasm during intracranial aneurysm surgery]. ( Han, RQ; Li, SR; Liu, W; Wang, BG; Wang, EZ; Wang, S; Zhao, JZ, 2004) |
| "To assess the cost-effectiveness ratio of nimodipine administration after aneurysmal subarachnoid hemorrhage (SAH) and surgery." | 9.09 | Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery. ( Karinen, P; Koivukangas, J; Koivukangas, P; Ohinmaa, A; Ohman, J, 1999) |
| "The selective intra-arterial nimodipine application for the treatment of cerebral vasospasm (CVS) in patients after spontaneous subarachnoid hemorrhage (sSAH) is widely employed." | 8.12 | Radiation exposure in the intra-arterial nimodipine therapy of subarachnoid hemorrhage related cerebral vasospasm. ( Bos, D; Deuschl, C; Dörner, N; Forsting, M; Guberina, N; Jabbarli, R; Kleinschnitz, C; Li, Y; Opitz, M; Radbruch, A; Sure, U; Uslar, E; Wetter, A; Zensen, S, 2022) |
| "Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and effect on brain perfusion is unknown." | 8.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "Intra-arterial nimodipine (IAN) injections are performed in refractory delayed cerebral ischemia (DCI) related to cerebral vasospasm (CVS) after spontaneous subarachnoid hemorrhage (sSAH), but the clinical benefits are inconclusive and angiographic treatment failure is observed." | 8.12 | Analysis of Angiographic Treatment Response to Intra-Arterial Nimodipine Bolus Injection in Patients with Medically Refractory Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage. ( Ditz, C; Küchler, J; Neumann, A; Schacht, H; Schramm, P; Tronnier, VM, 2022) |
| "The role of nimodipine and milrinone in the management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) was studied using clinical and TCD (transcranial Doppler) parameters." | 8.12 | Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia. ( Chakrabarti, D; Konar, SK; Kotwal, A; Radhakrishnan, M; Ramalingaiah, AH; Shukla, D; Srinivasaiah, B; Sundaram, M, 2022) |
| "This study aimed to discuss the influence of nimodipine+ulinastatin on the neurological function and inflammatory reaction in patients with cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH)." | 8.02 | Influence of nimodipine combined with ulinastatin on neurological function and inflammatory reaction in patients with cerebral vasospasm after subarachnoid hemorrhage. ( Chen, M; Liu, H; Wei, X; Zhang, Q; Zou, W, 2021) |
| "Our findings suggest that nimodipine administration via enteral feeding tubes may be associated with vasospasm and DCI in subarachnoid hemorrhage patients secondary to reduced exposure." | 7.96 | The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage. ( Abdallah, YEH; Isse, FA; Mahmoud, SH, 2020) |
| "Fifty-three percent of patients developed new cerebral infarction after intraarterial nimodipine and additional PTA in selected cases." | 7.91 | Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? ( Adami, D; Berkefeld, J; Konczalla, J; Pfeilschifter, W; Platz, J; Wagner, M; Weidauer, S, 2019) |
| "Long-term continuous intra-arterial nimodipine infusion (CIAN) is a rescue therapy option in cases of severe refractory cerebral vasospasm (CV) following acute non-traumatic subarachnoid hemorrhage (SAH)." | 7.88 | Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage. ( Bele, S; Flessa, J; Graf, B; Kieninger, M; Lindenberg, N; Redel, A; Schneiker, A; Schuierer, G; Silbereisen, V; Wendl, C, 2018) |
| "Intra-arterial (IA) administration of nimodipine has been shown to be an effective treatment for subarachnoid hemorrhage-related cerebral vasospasm." | 7.85 | Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm. ( Brockmann, C; Brockmann, MA; Groden, C; Hesser, J; Neumaier-Probst, E; Schubert, R; Seker, F, 2017) |
| "For the treatment and prevention of delayed cerebral ischemia after subarachnoid hemorrhage, the vasodilating agent nimodipine (NDP) is widely employed." | 7.85 | Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation. ( Birkenhauer, U; Diedler, J; Ernemann, U; Hockel, K; Schuhmann, MU; Steiner, J, 2017) |
| " In this study, the authors examined the effects of treatment with the NO donor molsidomine with regard to decreasing the incidence of spasm-related delayed brain infarctions and improving clinical outcome in patients with SAH." | 7.83 | Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. ( Brüning, R; Ehlert, A; Heindel, W; Hesselmann, V; Jacobs, AH; Manthei, G; Pluta, RM; Ringelstein, EB; Schmidt, C; Stummer, W; Wölfer, J, 2016) |
| "The incidence of cerebral infarction and poor outcome in patients with aneurysmal subarachnoid hemorrhage (aSAH) is reduced by oral nimodipine but acute effects of the drug may include a significant decrease in mean arterial blood pressure (MAP)." | 7.83 | Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage. ( Diesing, D; Sandow, N; Sarrafzadeh, A; Vajkoczy, P; Wolf, S, 2016) |
| "Records of children with a confirmed diagnosis of subarachnoid hemorrhage who received nimodipine between January 1, 2005 and August 31, 2013 were reviewed." | 7.81 | Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children. ( Heffren, J; McIntosh, AM; Reiter, PD, 2015) |
| "Nimodipine is a widely used medication for treating delayed cerebral ischemia (DCI) after subarachnoid hemorrhage." | 7.81 | Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model. ( Ahtola-Sätilä, T; Forsback, AP; Frantzén, J; Koskimäki, J; Laakso, A; Saloranta, L; Simola, O; Tarkia, M, 2015) |
| "In thirty patients with aneurysmal subarachnoid hemorrhage and refractory vasospasm continuous infusion of nimodipine was started on the neurosurgical intensive care unit." | 7.80 | Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. ( Jedlicka, S; Lumenta, CB; Merker, P; Ott, S; Peter, M; Pudenz, C; Schürer, L; Wolf, S, 2014) |
| "We sought to explore whether topical administration of nimodipine improves the abnormal cerebral perfusion following subarachnoid hemorrhage (SAH) in pigs." | 7.79 | Effects of topical administration of nimodipine on cerebral blood flow following subarachnoid hemorrhage in pigs. ( Jia, F; Jiang, JY; Wang, F; Yin, YH, 2013) |
| "Nimodipine improved outcome in patients with subarachnoid hemorrhage (SAH) although hypotension limited the dose that could be administered systemically." | 7.78 | Cisternal sustained release dihydropyridines for subarachnoid hemorrhage. ( Ai, J; Cook, DJ; Kan, S; Kasuya, H; Macdonald, RL, 2012) |
| "To investigate the effect of locally applied nimodipine prolonged-release microparticles on angiographic vasospasm and secondary brain injury after experimental subarachnoid hemorrhage (SAH)." | 7.78 | Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage. ( Bege, N; Beseoglu, K; Eicker, S; Etminan, N; Frauenknecht, K; Hänggi, D; Heiroth, HJ; Kamp, MA; Kissel, T; Macht, S; Perrin, J; Sommer, C; Steiger, HJ, 2012) |
| "the aim of this study was to assess and to compare the ability of intrathecal flunarizine and nimodipine to prevent vasospasm in a rabbit model of subarachnoid hemorrhage (SAH)." | 7.77 | Comparison of intrathecal flunarizine and nimodipine treatments in cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. ( Civelek, E; Gonul, E; Izci, Y; Kircelli, A; Onal, MB; Secer, HI; Solmaz, I; Temiz, C, 2011) |
| "This study evaluated the efficacy of intra-arterial nimodipine infusion for symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage (aSAH)." | 7.77 | Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. ( Cho, WS; Hang, MH; Jung, C; Kang, HS; Kim, JE; Know, BJ; Kwon, OK; Oh, CW; Son, YJ, 2011) |
| "We investigated the effect of ebselen relative to nimodipine in an animal model of subarachnoid hemorrhage." | 7.76 | Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats. ( Acikgoz, B; Acikgoz, S; Ankarali, H; Bahadir, B; Bektas, S; Gul, S; Hanci, V; Kalayci, M; Ugurbas, E, 2010) |
| "To explore the dose-response effects of topical administration of nimodipine on cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) in rabbits." | 7.75 | Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits. ( Jiang, JY; Luo, QZ; Pan, YH; Wang, F; Wang, Y; Yin, YH, 2009) |
| "Sixty-five male Wistar rats were randomized into 4 groups: the control sham-operated group, the control subarachnoid hemorrhage-only group, and the treatment groups receiving 5 or 10 microL/hour of intracisternal nimodipine continuously for 5 days via subcutaneously implanted Alzet osmotic pumps (Durect Corp." | 7.75 | Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model. ( Beseoglu, K; Eicker, S; Hänggi, D; Nawatny, J; Perrin, J; Rapp, M; Sommer, C; Steiger, HJ; Turowski, B, 2009) |
| "Our aim in this study was to investigate the efficacy of intravenous administration of cilostazol and compare these effects with intravenous usage of nimodipine in subarachnoid hemorrhage model." | 7.75 | The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model. ( Bilginer, B; Narin, F; Onal, MB; Ozgen, T; Soylemezoglu, F; Ziyal, IM, 2009) |
| "Cerebral vasospasm is a common complication of subarachnoid hemorrhage." | 6.72 | Side effects of continuous intra-arterial infusion of nimodipine for management of resistant cerebral vasospasm in subarachnoid hemorrhage patients: A systematic review. ( Bilotta, F; Sarria-Santamera, A; Viderman, D, 2021) |
| "Severe refractory cerebral vasospasm (CV) is a major cause of disability and death in patients with aneurysmal subarachnoid hemorrhage (SAH)." | 5.72 | Continuous intra-arterial nimodipine infusion as rescue treatment of severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage. ( Anthofer, J; Bele, S; Bruendl, E; Kieninger, M; Schebesch, KM; Schmidt, NO; Wendl, C; Zeman, F, 2022) |
| "Cerebral vasospasm (CV) and delayed cerebral ischemia (DCI) are major factors that limit good outcome in patients with spontaneous subarachnoid hemorrhage (SAH)." | 5.51 | The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation. ( Brand, C; Braun, M; Kapapa, T; König, R; Özpeynirci, Y; Paľa, A; Pedro, MT; Schmitz, B; Schneider, M; Wirtz, CR, 2019) |
| "Cerebral vasospasm following subarachnoid hemorrhage (SAH) is the most important complication that effects the mortality and morbidity of patients with intracranial aneurysm." | 5.46 | Comparison of the Effects and Mechanism of the Curcumin with Different Drugs in Experimental Vasospasm After Subarachnoid Hemorrhage. ( Aydin, HE; Baycu, C; Bektur, NE; Kilic, FS; Oner, S; Ozbek, Z, 2017) |
| " Key to the effective administration of continuous intra-arterial nimodipine is multimodal neuromonitoring and the individual adaptation of dosage and time of infusion for each patient." | 5.42 | Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results. ( Bele, S; Brawanski, A; Bründl, E; Hochreiter, A; Kieninger, M; Proescholdt, MA; Schebesch, KM; Scheitzach, J; Schneiker, A; Schödel, P; Schuierer, G; Wendl, C, 2015) |
| "These results are consistent with a beneficial effect of locally delivered nimodipine (EG-1962) on SD after aSAH in more severely injured patients who are at risk of delayed cerebral ischemia related to SD." | 5.41 | Effect of Locally Delivered Nimodipine Microparticles on Spreading Depolarization in Aneurysmal Subarachnoid Hemorrhage. ( Alchbli, A; Carlson, AP; Hänggi, D; Macdonald, RL; Shuttleworth, CW, 2021) |
| "Nimodipine treatment in cerebral vasospasm is useful." | 5.37 | Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits. ( Bilginer, B; Civelek, E; Isikay, I; Kircelli, A; Narin, F; Onal, MB; Solmaz, I; Ugurel, S; Yakupoglu, H, 2011) |
| "Nimodipine is an effect-proven agent in CVS, but dotarizine may take place of it." | 5.37 | Comparison of intrathecal dotarizine and nimodipine treatments in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits. ( Civelek, E; Erdogan, E; Gonul, E; Izci, Y; Kircelli, A; Onal, MB; Solmaz, I; Tehli, O, 2011) |
| "Nimodipine is a potent drug for vessel relaxation, but side effects may preclude a sufficient dose." | 5.37 | Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. ( Coburger, J; Henkes, H; Hopf, N; Musahl, C; Vajda, Z, 2011) |
| "Cerebral vasospasm complicating aneurysmal subarachnoid hemorrhage is a well-known medical entity." | 5.37 | Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion. ( Barth, H; Doukas, A; Jansen, O; Maslehaty, H; Mehdorn, HM; Petridis, AK, 2011) |
| "Brain hemodynamics in cerebral malaria (CM) is poorly understood, with apparently conflicting data showing microcirculatory hypoperfusion and normal or even increased blood flow in large arteries." | 5.36 | Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. ( Cabrales, P; Carvalho, LJ; Frangos, JA; Meays, D; Zanini, GM, 2010) |
| "One of the challenges in bringing new therapeutic agents (since nimodipine) in for the treatment of cerebral ischemia associated with aneurysmal subarachnoid hemorrhage (aSAH) is the incongruence in therapeutic benefit observed between phase II and subsequent phase III clinical trials." | 5.22 | Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage. ( Broderick, JP; Cassarly, CN; Huang, W; Ishfaq, MF; Lobanova, I; Macdonald, RL; Martin, RH; Qureshi, AI; Suarez, JI, 2022) |
| "Nimodipine and cilostazol are likely the most effective treatments in preventing morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage." | 5.22 | Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials. ( Ahmadvand, S; Amin-Hanjani, S; Dayyani, M; Grotta, JC; Guyatt, GH; Sadeghirad, B; Wang, Y; Zabihyan, S, 2022) |
| "Our objective was to compare the effectiveness of intravenous and enteral nimodipine in preventing poor outcome from delayed cerebral ischemia in patients with subarachnoid hemorrhage." | 5.22 | A Comparison Between Enteral and Intravenous Nimodipine in Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis. ( Boscolo, A; Cacco, N; Carere, A; Correale, C; De Cassai, A; Diana, P; Disarò, L; Geraldini, F; Munari, M; Navalesi, P; Zampirollo, S, 2022) |
| "Fasudil is believed to be at least equally effective as nimodipine for the prevention of cerebral vasospasm and subsequent ischemic injury in patients undergoing surgery for subarachnoid hemorrhage (SAH)." | 5.15 | Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. ( Guo, J; Mao, Y; Ren, Z; Wang, R; Wang, S; Xu, B; Zhang, X; Zhang, Y; Zhao, J; Zhao, K; Zhou, D; Zhou, L, 2011) |
| "The calcium antagonist nimodipine has been shown to reduce the incidence of ischemic complications following aneurysmal subarachnoid hemorrhage (SAH)." | 5.14 | Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. ( Cronqvist, M; Kronvall, E; Nilsson, OG; Romner, B; Säveland, H; Undrén, P, 2009) |
| "The efficacy of intra-arterial administration of nimodipine (IAN) in patients with severe vasospasm after aneurysmal subarachnoid hemorrhage (SAH) remains unproved." | 5.13 | Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion. ( Beseoglu, K; Hänggi, D; Steiger, HJ; Turowski, B; Yong, M, 2008) |
| "The prophylactic use of nimodipine in patients with aneurysmal subarachnoid hemorrhage reduces the risk of ischemic brain damage." | 5.12 | Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. ( Briegel, J; Kunz, M; Prueckner, S; Schmid-Elsaesser, R; Steiger, HJ; Zausinger, S, 2006) |
| " This randomized open trial with nimodipine as the control included 72 patients who underwent subarachnoid hemorrhage surgery for ruptured cerebral aneurysm of Hunt and Hess grades I to IV." | 5.12 | Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. ( Guo, J; Ren, Z; Wang, R; Wang, S; Xu, B; Zhao, J; Zhou, D; Zhou, L, 2006) |
| "Eleven patients with primary thunderclap headache (TCH) were treated with oral nimodipine 30 to 60 mg every 4 hours or IV nimodipine 0." | 5.11 | Nimodipine for treatment of primary thunderclap headache. ( Fuh, JL; Liao, YC; Lirng, JF; Lu, SR; Wang, SJ, 2004) |
| "Thirty consecutive patients under-going intracranial aneurysmal surgery were prospectively randomized into two groups: Isoflurane (group A, n = 15) and nimodipine (group B, n = 15)." | 5.11 | [The effect of intraoperative continuous nimodipine infusion on cerebral vasospasm during intracranial aneurysm surgery]. ( Han, RQ; Li, SR; Liu, W; Wang, BG; Wang, EZ; Wang, S; Zhao, JZ, 2004) |
| "To assess the cost-effectiveness ratio of nimodipine administration after aneurysmal subarachnoid hemorrhage (SAH) and surgery." | 5.09 | Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery. ( Karinen, P; Koivukangas, J; Koivukangas, P; Ohinmaa, A; Ohman, J, 1999) |
| " Clinical trials in subarachnoid hemorrhage have led to approval of nimodipine for oral and intravenous use, but other drugs, such as clazosentan, hydroxymethylglutaryl CoA reductase inhibitors (statins) and magnesium, have not shown consistent clinical efficacy." | 4.88 | Intracranial drug delivery for subarachnoid hemorrhage. ( Leung, M; Macdonald, RL; Tice, T, 2012) |
| "Nimodipine (Nimotop), HMG Co-A reductase inhibitor (statins) and enoxaparin (Lovenox) were the only drugs with level-1 evidence available for the treatment of vasospasm from aneurysmal subarachnoid hemorrhage as defined by the US Preventative Services Task Force." | 4.85 | Evidence-based pharmacotherapy for cerebral vasospasm. ( Boulos, AS; Deshaies, EM; Drazin, D; Popp, AJ, 2009) |
| "A total of 40 rabbits were used to make subarachnoid hemorrhage model and were divided into three groups - a control group, nimodipine group, and tadalafil group." | 4.31 | Vasodilatory effects of tadalafil in an animal model of cerebral vasospasm: Comparative analysis with oral nimodipine. ( Byoun, HS; Il Won, Y; Lim, J; Park, B; Park, KH; Youm, JY, 2023) |
| "The selective intra-arterial nimodipine application for the treatment of cerebral vasospasm (CVS) in patients after spontaneous subarachnoid hemorrhage (sSAH) is widely employed." | 4.12 | Radiation exposure in the intra-arterial nimodipine therapy of subarachnoid hemorrhage related cerebral vasospasm. ( Bos, D; Deuschl, C; Dörner, N; Forsting, M; Guberina, N; Jabbarli, R; Kleinschnitz, C; Li, Y; Opitz, M; Radbruch, A; Sure, U; Uslar, E; Wetter, A; Zensen, S, 2022) |
| "Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and effect on brain perfusion is unknown." | 4.12 | Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. ( Andereggen, L; Berberat, J; Ensner, R; Marbacher, S; Remonda, L; Steiger, HJ, 2022) |
| "Intra-arterial nimodipine (IAN) injections are performed in refractory delayed cerebral ischemia (DCI) related to cerebral vasospasm (CVS) after spontaneous subarachnoid hemorrhage (sSAH), but the clinical benefits are inconclusive and angiographic treatment failure is observed." | 4.12 | Analysis of Angiographic Treatment Response to Intra-Arterial Nimodipine Bolus Injection in Patients with Medically Refractory Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage. ( Ditz, C; Küchler, J; Neumann, A; Schacht, H; Schramm, P; Tronnier, VM, 2022) |
| "The role of nimodipine and milrinone in the management of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH) was studied using clinical and TCD (transcranial Doppler) parameters." | 4.12 | Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia. ( Chakrabarti, D; Konar, SK; Kotwal, A; Radhakrishnan, M; Ramalingaiah, AH; Shukla, D; Srinivasaiah, B; Sundaram, M, 2022) |
| "This study aimed to discuss the influence of nimodipine+ulinastatin on the neurological function and inflammatory reaction in patients with cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH)." | 4.02 | Influence of nimodipine combined with ulinastatin on neurological function and inflammatory reaction in patients with cerebral vasospasm after subarachnoid hemorrhage. ( Chen, M; Liu, H; Wei, X; Zhang, Q; Zou, W, 2021) |
| "Our findings suggest that nimodipine administration via enteral feeding tubes may be associated with vasospasm and DCI in subarachnoid hemorrhage patients secondary to reduced exposure." | 3.96 | The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage. ( Abdallah, YEH; Isse, FA; Mahmoud, SH, 2020) |
| "Fifty-three percent of patients developed new cerebral infarction after intraarterial nimodipine and additional PTA in selected cases." | 3.91 | Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? ( Adami, D; Berkefeld, J; Konczalla, J; Pfeilschifter, W; Platz, J; Wagner, M; Weidauer, S, 2019) |
| "Long-term continuous intra-arterial nimodipine infusion (CIAN) is a rescue therapy option in cases of severe refractory cerebral vasospasm (CV) following acute non-traumatic subarachnoid hemorrhage (SAH)." | 3.88 | Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage. ( Bele, S; Flessa, J; Graf, B; Kieninger, M; Lindenberg, N; Redel, A; Schneiker, A; Schuierer, G; Silbereisen, V; Wendl, C, 2018) |
| "Using PubMed and Google Scholar, we performed a search of the English language literature with several combinations of the keywords "intra-arterial", "calcium channel blockers", "reversible cerebral vasoconstriction syndrome", "RCVS", "nimodipine", "verapamil", "milrinone", and "nicardipine" to identify studies in which RCVS was treated with IA calcium channel blockers." | 3.88 | Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome ( Al-Mufti, F; Alchaki, A; Dodson, V; El-Ghanem, M; Gupta, G; Hidalgo, A; Nuoman, R; Roychowdhury, S; Sutherland, A; Thabet, A; Wajswol, E, 2018) |
| "Oral nimodipine is an established prophylactic agent for cerebral vasospasm after subarachnoid hemorrhage (SAH)." | 3.85 | Systemic and Cerebral Concentration of Nimodipine During Established and Experimental Vasospasm Treatment. ( Albanna, W; Clusmann, H; Conzen, C; Höllig, A; Müller, M; Reinsch, M; Schneider, T; Schubert, GA; Weiss, M; Wiesmann, M, 2017) |
| "Intra-arterial (IA) administration of nimodipine has been shown to be an effective treatment for subarachnoid hemorrhage-related cerebral vasospasm." | 3.85 | Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm. ( Brockmann, C; Brockmann, MA; Groden, C; Hesser, J; Neumaier-Probst, E; Schubert, R; Seker, F, 2017) |
| "For the treatment and prevention of delayed cerebral ischemia after subarachnoid hemorrhage, the vasodilating agent nimodipine (NDP) is widely employed." | 3.85 | Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation. ( Birkenhauer, U; Diedler, J; Ernemann, U; Hockel, K; Schuhmann, MU; Steiner, J, 2017) |
| " In this study, the authors examined the effects of treatment with the NO donor molsidomine with regard to decreasing the incidence of spasm-related delayed brain infarctions and improving clinical outcome in patients with SAH." | 3.83 | Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. ( Brüning, R; Ehlert, A; Heindel, W; Hesselmann, V; Jacobs, AH; Manthei, G; Pluta, RM; Ringelstein, EB; Schmidt, C; Stummer, W; Wölfer, J, 2016) |
| "The incidence of cerebral infarction and poor outcome in patients with aneurysmal subarachnoid hemorrhage (aSAH) is reduced by oral nimodipine but acute effects of the drug may include a significant decrease in mean arterial blood pressure (MAP)." | 3.83 | Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage. ( Diesing, D; Sandow, N; Sarrafzadeh, A; Vajkoczy, P; Wolf, S, 2016) |
| "Records of children with a confirmed diagnosis of subarachnoid hemorrhage who received nimodipine between January 1, 2005 and August 31, 2013 were reviewed." | 3.81 | Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children. ( Heffren, J; McIntosh, AM; Reiter, PD, 2015) |
| "Nimodipine is a widely used medication for treating delayed cerebral ischemia (DCI) after subarachnoid hemorrhage." | 3.81 | Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model. ( Ahtola-Sätilä, T; Forsback, AP; Frantzén, J; Koskimäki, J; Laakso, A; Saloranta, L; Simola, O; Tarkia, M, 2015) |
| "In thirty patients with aneurysmal subarachnoid hemorrhage and refractory vasospasm continuous infusion of nimodipine was started on the neurosurgical intensive care unit." | 3.80 | Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. ( Jedlicka, S; Lumenta, CB; Merker, P; Ott, S; Peter, M; Pudenz, C; Schürer, L; Wolf, S, 2014) |
| "We sought to explore whether topical administration of nimodipine improves the abnormal cerebral perfusion following subarachnoid hemorrhage (SAH) in pigs." | 3.79 | Effects of topical administration of nimodipine on cerebral blood flow following subarachnoid hemorrhage in pigs. ( Jia, F; Jiang, JY; Wang, F; Yin, YH, 2013) |
| "Nimodipine improved outcome in patients with subarachnoid hemorrhage (SAH) although hypotension limited the dose that could be administered systemically." | 3.78 | Cisternal sustained release dihydropyridines for subarachnoid hemorrhage. ( Ai, J; Cook, DJ; Kan, S; Kasuya, H; Macdonald, RL, 2012) |
| "To investigate the effect of locally applied nimodipine prolonged-release microparticles on angiographic vasospasm and secondary brain injury after experimental subarachnoid hemorrhage (SAH)." | 3.78 | Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage. ( Bege, N; Beseoglu, K; Eicker, S; Etminan, N; Frauenknecht, K; Hänggi, D; Heiroth, HJ; Kamp, MA; Kissel, T; Macht, S; Perrin, J; Sommer, C; Steiger, HJ, 2012) |
| "the aim of this study was to assess and to compare the ability of intrathecal flunarizine and nimodipine to prevent vasospasm in a rabbit model of subarachnoid hemorrhage (SAH)." | 3.77 | Comparison of intrathecal flunarizine and nimodipine treatments in cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. ( Civelek, E; Gonul, E; Izci, Y; Kircelli, A; Onal, MB; Secer, HI; Solmaz, I; Temiz, C, 2011) |
| "the aim of this study was to assess and to compare the ability of intrathecal nicergoline and nimodipine in prevention of cerebral vasospasm in a rabbit model of subarachnoid hemorrhage (SAH)." | 3.77 | The effects of intrathecal nicergoline and nimodipine in cerebral vasospasm: an experimental study in rabbits. ( Civelek, E; Erdogan, E; Gonul, E; Kircelli, A; Onal, MB; Ongoru, O; Solmaz, I; Ugurel, S, 2011) |
| "This study evaluated the efficacy of intra-arterial nimodipine infusion for symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage (aSAH)." | 3.77 | Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. ( Cho, WS; Hang, MH; Jung, C; Kang, HS; Kim, JE; Know, BJ; Kwon, OK; Oh, CW; Son, YJ, 2011) |
| "For endovascular treatment of vasospasm after aneurysmal subarachnoid hemorrhage (aSAH), an intraarterial treatment course with the calcium channel antagonist nimodipine infused for 30 min is proposed." | 3.76 | Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. ( Landscheidt, JF; Lumenta, CB; Martin, H; Rodiek, SO; Schürer, L; Wolf, S, 2010) |
| "We investigated the effect of ebselen relative to nimodipine in an animal model of subarachnoid hemorrhage." | 3.76 | Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats. ( Acikgoz, B; Acikgoz, S; Ankarali, H; Bahadir, B; Bektas, S; Gul, S; Hanci, V; Kalayci, M; Ugurbas, E, 2010) |
| "To explore the dose-response effects of topical administration of nimodipine on cerebral vasospasm (CVS) after subarachnoid hemorrhage (SAH) in rabbits." | 3.75 | Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits. ( Jiang, JY; Luo, QZ; Pan, YH; Wang, F; Wang, Y; Yin, YH, 2009) |
| "Sixty-five male Wistar rats were randomized into 4 groups: the control sham-operated group, the control subarachnoid hemorrhage-only group, and the treatment groups receiving 5 or 10 microL/hour of intracisternal nimodipine continuously for 5 days via subcutaneously implanted Alzet osmotic pumps (Durect Corp." | 3.75 | Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model. ( Beseoglu, K; Eicker, S; Hänggi, D; Nawatny, J; Perrin, J; Rapp, M; Sommer, C; Steiger, HJ; Turowski, B, 2009) |
| "Our aim in this study was to investigate the efficacy of intravenous administration of cilostazol and compare these effects with intravenous usage of nimodipine in subarachnoid hemorrhage model." | 3.75 | The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model. ( Bilginer, B; Narin, F; Onal, MB; Ozgen, T; Soylemezoglu, F; Ziyal, IM, 2009) |
| "Nimodipine is a therapy that reduces morbidity and mortality in patients with subarachnoid hemorrhage (SAH), though the mechanisms by which it does so are not well understood." | 3.73 | Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm. ( Chen, FX; Eastwood, JD; Laslo, AM; Lee, TY, 2006) |
| "The efficacy of nimodipine was examined in a murine model of subarachnoid hemorrhage (SAH)." | 3.73 | Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. ( Borel, CO; Laskowitz, DT; Lombard, FW; Mesis, RG; Vitek, MP; Wang, H; Warner, DS; Yates, R, 2006) |
| " Cerebral vasospasm (CV) after aneurysmal subarachnoid hemorrhage (aSAH) is still a problem." | 3.11 | Clinical Outcome in Cerebral Vasospasm Patients Treated with and without Intra-Arterial Nimodipine Infusion. ( Nimmannitya, P; Noiphithak, R; Punyarat, P; Tantongtip, D; Yindeedej, V, 2022) |
| "Cerebral vasospasm is one of the frequent complications that can occur following subarachnoid hemorrhage (SAH)." | 3.01 | Cerebral Vasospasm: Practical Review of Diagnosis and Management. ( Artico, M; Berger, JM; Caramuta, M; Longhitano, Y; Maconi, A; Piccolella, F; Romenskaya, T; Saviano, A; Savioli, G; Taurone, S; Zanza, C, 2023) |
| " However, 4-hourly dosing is a practical limitation and verapamil has been proposed as an alternative." | 3.01 | Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review. ( Bacchi, S; Bagster, M; Collins, L; Goh, R; Gupta, A; Kleinig, O; Kleinig, T; Kovoor, J; Lam, L; Proudman, W; Schultz, D; Zhang, R, 2023) |
| "Poor outcomes in Subarachnoid Hemorrhage (SAH) are in part due to a unique form of secondary neurological injury known as Delayed Cerebral Ischemia (DCI)." | 3.01 | Cortical Spreading Depolarization and Delayed Cerebral Ischemia; Rethinking Secondary Neurological Injury in Subarachnoid Hemorrhage. ( Bischof, H; Diedrich, D; Gomez, F; Laudanski, K; Mehra, A, 2023) |
| "Aneurysmal subarachnoid hemorrhage (aSAH) is a severe subtype of stroke occurring at a relatively young age with a significant socioeconomic impact." | 2.82 | Therapeutic Approaches for Cerebrovascular Dysfunction After Aneurysmal Subarachnoid Hemorrhage: An Update and Future Perspectives. ( Grasso, G; Torregrossa, F, 2022) |
| "Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening condition associated with the development of early brain injury (EBI) and delayed cerebral ischemia (DCI)." | 2.72 | Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review. ( Jancalek, R; Joukal, M; Mackerle, Z; Solar, P, 2021) |
| "Cerebral vasospasm is a common complication of subarachnoid hemorrhage." | 2.72 | Side effects of continuous intra-arterial infusion of nimodipine for management of resistant cerebral vasospasm in subarachnoid hemorrhage patients: A systematic review. ( Bilotta, F; Sarria-Santamera, A; Viderman, D, 2021) |
| "Nimodipine has a good effect on releasing spasm and diminishing the cerebral blood flow velocity." | 2.70 | Mechanism and treatment principle for cerebral vessel spasm caused by concussion. ( Guo, X; Wang, D; Xiao, X; Xue, G, 2002) |
| "Aneurysmal subarachnoid hemorrhage (aSAH) represents 3% of all strokes in the US." | 2.58 | Investigational drugs for vasospasm after subarachnoid hemorrhage. ( Freeman, WD; Pizzi, MA; Tallarico, RT, 2018) |
| "Early treatment of ruptured aneurysms is advocated; delayed intervention complicates the treatment strategy leading to significant vasospasm and poor prognosis." | 2.58 | Coadjuvant Treatment of Vasospasm in Ruptured Unsecured Cerebral Aneurysms with Aggressive Angioplasty, Intra-Arterial Nimodipine, and Aneurysm Embolization. ( Chen, CC; Chen, CT; Hsieh, PC; Yi-Chou Wang, A, 2018) |
| "Bath-related headache is a rare form of thunderclap headache." | 2.58 | Bath-Related Headache. ( Kumpinsky, A; Nahas, SJ, 2018) |
| "Large-vessel cerebral vasospasm has been challenged as the sole causal mechanism; new hypotheses now focus on the early brain injury, microcirculatory dysfunction, impaired autoregulation, and spreading depolarization." | 2.53 | Management of delayed cerebral ischemia after subarachnoid hemorrhage. ( Francoeur, CL; Mayer, SA, 2016) |
| "Outcome of patients with aneurysmal subarachnoid hemorrhage (SAH) has improved over the last decades." | 2.49 | SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials. ( Cusimano, MD; Etminan, N; Hanggi, D; Hasan, D; Ilodigwe, D; Jaja, B; Lantigua, H; Le Roux, P; Lo, B; Louffat-Olivares, A; Macdonald, RL; Mayer, S; Molyneux, A; Quinn, A; Schenk, T; Schweizer, TA; Singh, J; Spears, J; Todd, M; Torner, J; Vergouwen, MD; Wong, GK, 2013) |
| "This process, known as cerebral vasospasm, is the most common cause of DCI after SAH." | 2.48 | Management of delayed cerebral ischemia after subarachnoid hemorrhage. ( Koenig, MA, 2012) |
| "Aneurysmal subarachnoid hemorrhage (SAH) accounts for a significant percentage of morbidity and mortality among patients admitted to neurosurgical centers throughout the world." | 2.46 | Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage. ( Cook, AM; Ramsey, CN; Weant, KA, 2010) |
| "Resolution of ongoing cerebral vasospasm can be achieved by either dilating constricted vessels or optimizing hemodynamics." | 2.43 | Detecting and treating microvascular ischemia after subarachnoid hemorrhage. ( Sakowitz, OW; Unterberg, AW, 2006) |
| "Among patients with symptomatic cerebral vasospasm around 1/3 fully recover in 1/3 of cases persistent neurological deficit remains and 1/3 of the patients die." | 2.41 | [Cerebral vasospasm after subarachnoid hemorrhage. Current possibilities of prevention and treatment]. ( Danilewicz, B; Stachura, K, 2002) |
| "Severe refractory cerebral vasospasm (CV) is a major cause of disability and death in patients with aneurysmal subarachnoid hemorrhage (SAH)." | 1.72 | Continuous intra-arterial nimodipine infusion as rescue treatment of severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage. ( Anthofer, J; Bele, S; Bruendl, E; Kieninger, M; Schebesch, KM; Schmidt, NO; Wendl, C; Zeman, F, 2022) |
| "Delayed cerebral ischemia (DCI) contributes to poor outcomes after subarachnoid hemorrhage (SAH)." | 1.72 | Large practice variations in diagnosis and treatment of delayed cerebral ischemia after subarachnoid hemorrhage. ( Coert, BA; Coutinho, JM; Horn, J; Post, R; Tjerkstra, MA; van den Berg, R; Vandertop, WP; Verbaan, D, 2022) |
| "Patients with refractory cerebral vasospasm treated with intra-arterial nimodipine during 2009-2020 at Sahlgrenska University Hospital were retrospectively reviewed." | 1.72 | Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid haemorrhage - neurological and radiological outcome. ( Nilsson, D; Rentzos, A; Samuelsson, J; Sunila, M, 2022) |
| " Dose-response curves for the 5-HT-induced contraction (from 0." | 1.62 | The combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats. ( Crespo, MJ; García, L; Morales, M; Román, M, 2021) |
| "After spontaneous subarachnoid hemorrhage (sSAH), cerebral vasospasm (CVS) is a common complication, potentially resulting in infarction mainly responsible for a poor outcome." | 1.56 | Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience. ( Boppel, T; Ditz, C; Küchler, J; Leppert, J; Neumann, A; Schacht, H; Schramm, P, 2020) |
| " In cases of spontaneous subarachnoid hemorrhage (sSAH) and symptomatic cerebral vasospasm (sCVS), multiple intra-arterial treatments (IATs) can be potentially useful for the functional outcome, even if the prognosis is initially poor." | 1.56 | Symptomatic Cerebral Vasospasm after Spontaneous Subarachnoid Hemorrhage: Comparison of Single and Multiple Intra-arterial Treatment with Respect to the Functional Outcome. ( Aulmann, L; Ditz, C; Küchler, JN; Neumann, A; Schacht, H; Schramm, P; Tronnier, VM, 2020) |
| "Background and Purpose- Delayed cerebral infarction (DCI) is an important cause of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH)." | 1.56 | Impact of Stereotactic Ventriculocisternostomy on Delayed Cerebral Infarction and Outcome After Subarachnoid Hemorrhage. ( Bardutzky, J; Beck, J; Buttler, J; Coenen, VA; Csok, I; Egger, K; Grauvogel, J; Niesen, WD; Reinacher, PC; Roelz, R; Rohr, E; Sajonz, B; Schaefer, JH; Scheiwe, C; Shah, MJ; Steiert, C, 2020) |
| "This study aims to investigate the effect of nimodipine combined with betahistine on the levels of CRP and other inflammatory cytokines, as well as vascular endothelial function in patients with hypertensive cerebral vasospasm." | 1.56 | Effects of nimodipine combined with betahistine on CRP and other inflammatory cytokines and vascular endothelial function in patients with hypertensive cerebral vasospasm. ( Liu, X; Luo, X; Sheng, P; Wang, Y; Xiao, P; Zeng, K; Zhao, N, 2020) |
| "IaN for aSAH-related cerebral vasospasm did not improve rScO2 but was associated with significant systemic hemodynamic effects, including a decrease in MBP and TPRI." | 1.56 | Effect of Intra-arterial Nimodipine on Cerebral Oxygen Saturation and Systemic Hemodynamic Indices in Patients With Cerebral Vasospasm: A Prospective Cohort Study. ( Palaniswamy, SR; Ramalingaiah, AH; Sriganesh, K; Venkataramaiah, S, 2020) |
| "Cerebral vasospasm (CV) and delayed cerebral ischemia (DCI) are major factors that limit good outcome in patients with spontaneous subarachnoid hemorrhage (SAH)." | 1.51 | The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation. ( Brand, C; Braun, M; Kapapa, T; König, R; Özpeynirci, Y; Paľa, A; Pedro, MT; Schmitz, B; Schneider, M; Wirtz, CR, 2019) |
| "Delayed Cerebral Infarction (DCI) due to Cerebral Vasospasm (CVS) is an important contributor to poor outcome after aneurysmal subarachnoid haemorrhage (aSAH)." | 1.51 | A novel rescue therapy for cerebral vasospasm: Cisternal Nimodipine application via stereotactic catheter ventriculocisternostomy. ( Coenen, VA; Reinacher, PC; Roelz, R; Scheiwe, C, 2019) |
| "Moreover, MN-08 also alleviated cerebral vasospasm in a cisterna magna single-injection model in rabbits." | 1.51 | The dual-functional memantine nitrate MN-08 alleviates cerebral vasospasm and brain injury in experimental subarachnoid haemorrhage models. ( Guo, B; Han, Y; Ju, J; Li, N; Li, S; Liu, Z; Luo, F; Mak, S; Sun, Y; Wang, Y; Wu, L; Yang, X; Zhang, G; Zhang, Z; Zhou, Q; Zhu, Z, 2019) |
| "Cerebral vasospasm is a major contributor to DCI and requires special attention." | 1.51 | Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: More is more. ( Beck, J; Darkwah Oppong, M; Forsting, M; Jabbarli, R; Kaier, K; Mönninghoff, C; Pierscianek, D; Rölz, R; Shah, M; Sure, U; Taschner, C; Urbach, H, 2019) |
| "Nimodipine has improving effects on CVS in different degrees, and TCCS can be used to evaluate the therapeutic effects on CVS." | 1.46 | Evaluation function of transcranial two-dimensional and color Doppler ultrasonography (TCCS) for patients with different degrees of cerebral vasospasm before and after the nimodipine treatment. ( Li, X; Li, XN; Wang, JL; Yang, YL; Zhang, YH, 2017) |
| "Background Cerebral vasospasm (CV) is a major cause of delayed morbidity and mortality in patients with subarachnoid hemorrhage (SAH)." | 1.46 | Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm. ( Dogan, R; Duman, E; Fırat, A; Karakoç, F; Pinar, HU; Yıldırım, E, 2017) |
| "Cerebral vasospasm following subarachnoid hemorrhage (SAH) is the most important complication that effects the mortality and morbidity of patients with intracranial aneurysm." | 1.46 | Comparison of the Effects and Mechanism of the Curcumin with Different Drugs in Experimental Vasospasm After Subarachnoid Hemorrhage. ( Aydin, HE; Baycu, C; Bektur, NE; Kilic, FS; Oner, S; Ozbek, Z, 2017) |
| "In aneurysmal subarachnoid haemorrhage cerebral vasospasm leads to clinical worsening and poor outcome." | 1.46 | Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm. ( Doukas, A; Jansen, O; Larsen, N; Mehdorn, M; Stopfer, A; Synowitz, M; von der Brelie, C, 2017) |
| "Timely detection of impending delayed cerebral ischemia after subarachnoid hemorrhage (SAH) is essential to improve outcome, but poses a diagnostic challenge." | 1.43 | Retinal Vessel Analysis (RVA) in the Context of Subarachnoid Hemorrhage - A Proof of Concept Study. ( Albanna, W; Brockmann, MA; Clusmann, H; Conzen, C; Fuest, M; Hoellig, A; Kotliar, K; Mueller, M; Schmidt-Trucksäss, A; Schubert, GA; Seiz, M; Thomé, C; Vilser, W; Weiss, M, 2016) |
| "Milrinone was recently suggested as an invasive VSP treatment option." | 1.42 | Repeated combined endovascular therapy with milrinone and nimodipine for the treatment of severe vasospasm: preliminary results. ( Karaic, R; Kleinpeter, G; Krafft, P; Loyoddin, M; Sherif, C; Tscholakoff, D; Valentin, A; Wambacher, B, 2015) |
| "Verapamil was the most common first-line therapy in the United States, whereas nimodipine was most popular in non-U." | 1.42 | Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia. ( Bulsara, KR; Chen, PR; Coulthard, A; Goddard, AJ; Hollingworth, M; Söderman, M, 2015) |
| " Key to the effective administration of continuous intra-arterial nimodipine is multimodal neuromonitoring and the individual adaptation of dosage and time of infusion for each patient." | 1.42 | Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results. ( Bele, S; Brawanski, A; Bründl, E; Hochreiter, A; Kieninger, M; Proescholdt, MA; Schebesch, KM; Scheitzach, J; Schneiker, A; Schödel, P; Schuierer, G; Wendl, C, 2015) |
| "Diffuse cerebral vasospasm is a rare complication following tumour resection." | 1.40 | Diffuse cerebral vasospasm following resection of a hypoglossal schwannoma in a child. ( Afshari, FT; Fernandes, HM; Fitzgerald, JJ; Garnett, MR; Higgins, JN; Santarius, T, 2014) |
| "The authors describe a rare case of central auditory dysfunction induced by cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH)." | 1.39 | Partly reversible central auditory dysfunction induced by cerebral vasospasm after subarachnoid hemorrhage. ( Deggouj, N; Duprez, T; Grandin, C; Hantson, P; Lhommel, R; Ponzetto, E; van Pesch, V; Vinetti, M, 2013) |
| "Cerebral vasospasm is a severe complication of subarachnoid hemorrhage (SAH)." | 1.39 | Dose-response relationship of locally applied nimodipine in an ex vivo model of cerebral vasospasm. ( Brockmann, C; Brockmann, MA; Groden, C; Hesser, J; Neumaier-Probst, E; Schubert, R; Seker, F, 2013) |
| "Twenty (20) patients with SAH were treated after their ruptured aneurysms had been secured." | 1.39 | Acupuncture for cerebral vasospasm after subarachnoid hemorrhage: a retrospective case-control study. ( Bae, HS; Cho, SY; Kim, GK; Ko, CN; Koh, JS; Lee, IW; Lee, SH; Park, JM; Park, SU, 2013) |
| "To determine if the age of packed red blood cells (PRBCs) is associated with adverse events or outcomes in patients with subarachnoid haemorrhage (SAH)." | 1.37 | Packed red blood cell age does not impact adverse events or outcomes after subarachnoid haemorrhage. ( Ault, ML; Duran, IM; Liebling, SM; Naidech, AM, 2011) |
| "Nimodipine treatment in cerebral vasospasm is useful." | 1.37 | Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits. ( Bilginer, B; Civelek, E; Isikay, I; Kircelli, A; Narin, F; Onal, MB; Solmaz, I; Ugurel, S; Yakupoglu, H, 2011) |
| "Nimodipine is an effect-proven agent in CVS, but dotarizine may take place of it." | 1.37 | Comparison of intrathecal dotarizine and nimodipine treatments in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits. ( Civelek, E; Erdogan, E; Gonul, E; Izci, Y; Kircelli, A; Onal, MB; Solmaz, I; Tehli, O, 2011) |
| "Nimodipine is a potent drug for vessel relaxation, but side effects may preclude a sufficient dose." | 1.37 | Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. ( Coburger, J; Henkes, H; Hopf, N; Musahl, C; Vajda, Z, 2011) |
| "Cerebral vasospasm is the persistent constriction of large conduit arteries in the base of the brain." | 1.37 | Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery. ( Brueggemann, LI; Byron, KL; Cribbs, LL; Mani, BK, 2011) |
| "Nonaneurysmal perimesencephalic subarachnoid hemorrhage (SAH) has usually a benign prognosis and uneventful course; however, recent reports suggest that these patients may develop severe symptomatic vasospasm." | 1.37 | Endovascular treatment of severe vasospasm in nonaneurysmal perimesencephalic subarachnoid hemorrhage. ( Dabus, G; Fuentes, K; Linfante, I; Samaniego, EA, 2011) |
| "Cerebral vasospasm complicating aneurysmal subarachnoid hemorrhage is a well-known medical entity." | 1.37 | Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion. ( Barth, H; Doukas, A; Jansen, O; Maslehaty, H; Mehdorn, HM; Petridis, AK, 2011) |
| " We describe a patient with an apparent primary TCH, which repeatedly occurred immediately after micturition until she achieved a therapeutic dosage of nimodipine." | 1.37 | Thunderclap headache triggered by micturition: responsive to nimodipine. ( Gui, W; Han, YY; Liu, YM; Wang, K; Wang, Y; Zhu, J, 2011) |
| "Brain hemodynamics in cerebral malaria (CM) is poorly understood, with apparently conflicting data showing microcirculatory hypoperfusion and normal or even increased blood flow in large arteries." | 1.36 | Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. ( Cabrales, P; Carvalho, LJ; Frangos, JA; Meays, D; Zanini, GM, 2010) |
| " There were no serious adverse effects observed." | 1.35 | Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. ( Beseoglu, K; Hänggi, D; Steiger, HJ; Turowski, B, 2008) |
| "Rabbits symptomatic cerebral vasospasm model was built though Endo method, among the 40 rabbits, 8 died or had severe nervous system syndrome, the other 32 were randomly divided into 4 groups:group A, control group, injection of normal saline to the cisterna magna;group B, subarachnoid hemorrhage;group C, injection of human urinary tissue kallikreins;group D, treated with Nimodipine." | 1.35 | [Effects of human urinary tissue kallikreins on vasodilation of basilar artery in rabbits with symptomatic cerebral vasospasm]. ( Chen, WJ; Hu, ZY; Meng, YN; Mo, YC; Pei, SL; Wang, JL; Zhou, LP, 2009) |
| "Despite rigorous efforts, cerebral vasospasm remains an important cause of morbidity and mortality in patients who survive their initial subarachnoid hemorrhage." | 1.35 | Continuous intra-arterial infusion of nimodipine during embolization of cerebral aneurysms associated with vasospasm. ( Cinar, C; Oran, I, 2008) |
| "Here we describe a patient with a thunderclap headache and a mid-basilar narrowing due to a reversible vasospasm." | 1.33 | [Idiopathic thunderclap headache: reversible vasospasm of the Arteria basilaris]. ( Bruening, R; Plendl, H; Straube, A, 2006) |
| "Bathing headache is rarely described in literature." | 1.32 | Bathing headache: a variant of idiopathic thunderclap headache. ( Fuh, JL; Liao, YC; Lirng, JF; Lu, SR; Wang, SJ; Wu, ZA, 2003) |
| "During the following 2 weeks, the cerebral vasospasm resolved with application of high-dose methyl prednisolone and nimodipine." | 1.32 | [Cerebral vasospasms with hemodynamic infarctions as a complication of HELLP syndrome]. ( Bloos, G; Harscher, S; Möller, U; Pfleiderer, SO; Terborg, C; Witte, OW, 2003) |
| "The morbidity and mortality of cerebral vasospasm is significant." | 1.31 | Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience. ( Alp, MS; Ausman, J; Charbel, F; Corsten, L; Debrun, G; Guppy, K; Misra, M; Raja, A; Roitberg, B, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.53) | 18.2507 |
| 2000's | 48 (25.40) | 29.6817 |
| 2010's | 96 (50.79) | 24.3611 |
| 2020's | 44 (23.28) | 2.80 |
| Authors | Studies |
|---|---|
| Opitz, M | 1 |
| Zensen, S | 1 |
| Bos, D | 1 |
| Wetter, A | 1 |
| Kleinschnitz, C | 1 |
| Uslar, E | 1 |
| Jabbarli, R | 2 |
| Sure, U | 2 |
| Radbruch, A | 1 |
| Li, Y | 1 |
| Dörner, N | 1 |
| Forsting, M | 2 |
| Deuschl, C | 1 |
| Guberina, N | 1 |
| Chen, M | 1 |
| Zhang, Q | 1 |
| Liu, H | 1 |
| Zou, W | 1 |
| Wei, X | 1 |
| Roelz, R | 3 |
| Scheiwe, C | 3 |
| Grauvogel, J | 2 |
| Csok, I | 2 |
| Coenen, VA | 3 |
| Beck, J | 3 |
| Reinacher, PC | 3 |
| Anthofer, J | 1 |
| Bele, S | 3 |
| Wendl, C | 3 |
| Kieninger, M | 3 |
| Zeman, F | 1 |
| Bruendl, E | 1 |
| Schmidt, NO | 1 |
| Schebesch, KM | 2 |
| Yindeedej, V | 1 |
| Nimmannitya, P | 1 |
| Noiphithak, R | 1 |
| Punyarat, P | 1 |
| Tantongtip, D | 1 |
| Qureshi, AI | 1 |
| Lobanova, I | 1 |
| Huang, W | 1 |
| Ishfaq, MF | 1 |
| Broderick, JP | 1 |
| Cassarly, CN | 1 |
| Martin, RH | 1 |
| Macdonald, RL | 7 |
| Suarez, JI | 1 |
| Tjerkstra, MA | 1 |
| Verbaan, D | 1 |
| Coert, BA | 1 |
| Post, R | 1 |
| van den Berg, R | 1 |
| Coutinho, JM | 1 |
| Horn, J | 1 |
| Vandertop, WP | 1 |
| Steiger, HJ | 7 |
| Ensner, R | 1 |
| Andereggen, L | 1 |
| Remonda, L | 1 |
| Berberat, J | 1 |
| Marbacher, S | 2 |
| Torregrossa, F | 1 |
| Grasso, G | 1 |
| Schacht, H | 4 |
| Küchler, J | 3 |
| Neumann, A | 4 |
| Schramm, P | 4 |
| Tronnier, VM | 2 |
| Ditz, C | 3 |
| Dayyani, M | 1 |
| Sadeghirad, B | 1 |
| Grotta, JC | 1 |
| Zabihyan, S | 1 |
| Ahmadvand, S | 1 |
| Wang, Y | 6 |
| Guyatt, GH | 1 |
| Amin-Hanjani, S | 1 |
| Geraldini, F | 1 |
| De Cassai, A | 1 |
| Diana, P | 1 |
| Correale, C | 1 |
| Boscolo, A | 1 |
| Zampirollo, S | 1 |
| Disarò, L | 1 |
| Carere, A | 1 |
| Cacco, N | 1 |
| Navalesi, P | 1 |
| Munari, M | 1 |
| Mallereau, CH | 1 |
| Ribeiro, M | 1 |
| Ardellier, FD | 1 |
| Dannhoff, G | 1 |
| Cebula, H | 1 |
| Proust, F | 1 |
| Chibbaro, S | 1 |
| Todeschi, J | 1 |
| Kotwal, A | 1 |
| Ramalingaiah, AH | 2 |
| Shukla, D | 1 |
| Radhakrishnan, M | 1 |
| Konar, SK | 1 |
| Srinivasaiah, B | 1 |
| Chakrabarti, D | 1 |
| Sundaram, M | 1 |
| Romenskaya, T | 1 |
| Longhitano, Y | 1 |
| Piccolella, F | 1 |
| Berger, JM | 1 |
| Artico, M | 1 |
| Taurone, S | 1 |
| Maconi, A | 1 |
| Saviano, A | 1 |
| Caramuta, M | 1 |
| Savioli, G | 1 |
| Zanza, C | 1 |
| Khanafer, A | 1 |
| Cimpoca, A | 1 |
| Bhogal, P | 1 |
| Bäzner, H | 1 |
| Ganslandt, O | 1 |
| Henkes, H | 2 |
| Fiamingo, G | 1 |
| Canavero, I | 1 |
| Gastaldi, M | 1 |
| Coloberti, E | 1 |
| Buongarzone, G | 1 |
| Ghiotto, N | 1 |
| Bacila, A | 1 |
| Costa, A | 1 |
| Ravaglia, S | 1 |
| Collins, L | 1 |
| Lam, L | 1 |
| Kleinig, O | 1 |
| Proudman, W | 1 |
| Zhang, R | 1 |
| Bagster, M | 1 |
| Kovoor, J | 1 |
| Gupta, A | 1 |
| Goh, R | 1 |
| Bacchi, S | 1 |
| Schultz, D | 1 |
| Kleinig, T | 1 |
| Mehra, A | 1 |
| Gomez, F | 1 |
| Bischof, H | 1 |
| Diedrich, D | 1 |
| Laudanski, K | 1 |
| Youm, JY | 1 |
| Park, B | 1 |
| Park, KH | 1 |
| Il Won, Y | 1 |
| Byoun, HS | 1 |
| Lim, J | 1 |
| Weber, W | 1 |
| Jensen-Kondering, U | 1 |
| Berlis, A | 1 |
| Mindt, S | 1 |
| Tokhi, U | 1 |
| Hedtke, M | 1 |
| Groß, HJ | 1 |
| Hänggi, D | 10 |
| Cottenceau, V | 1 |
| Poutier, B | 1 |
| Gariel, F | 1 |
| Sauvage, N | 1 |
| Petit, L | 1 |
| Carrie, C | 1 |
| Biais, M | 1 |
| Hawkes, MA | 1 |
| Hlavnicka, AA | 1 |
| Wainsztein, NA | 1 |
| Boppel, T | 1 |
| Leppert, J | 1 |
| Aulmann, L | 1 |
| Küchler, JN | 1 |
| Schaefer, JH | 1 |
| Sajonz, B | 1 |
| Steiert, C | 1 |
| Buttler, J | 1 |
| Rohr, E | 1 |
| Shah, MJ | 1 |
| Egger, K | 1 |
| Niesen, WD | 1 |
| Bardutzky, J | 1 |
| Howarth, H | 1 |
| Mandal, AKJ | 1 |
| Boyd, E | 1 |
| Missouris, CG | 1 |
| Román, M | 2 |
| Ramírez, JM | 1 |
| Morales, M | 2 |
| Crespo, MJ | 2 |
| Carlson, AP | 1 |
| Alchbli, A | 1 |
| Shuttleworth, CW | 1 |
| Solar, P | 1 |
| Mackerle, Z | 1 |
| Joukal, M | 1 |
| Jancalek, R | 1 |
| Liu, X | 1 |
| Zhao, N | 1 |
| Zeng, K | 1 |
| Xiao, P | 1 |
| Sheng, P | 1 |
| Luo, X | 1 |
| Isse, FA | 1 |
| Abdallah, YEH | 1 |
| Mahmoud, SH | 1 |
| Chen, CT | 2 |
| Chen, CC | 2 |
| Wang, AY | 1 |
| Wu, YM | 1 |
| Chin, SC | 1 |
| Hsieh, PC | 2 |
| Yeap, MC | 1 |
| Hsu, SY | 1 |
| Lin, YJ | 1 |
| Allen, A | 1 |
| Raz, E | 1 |
| Huang, P | 1 |
| Rostanski, SK | 1 |
| McGowan, B | 1 |
| Khaira, G | 1 |
| Coghlan, MA | 1 |
| Shaibani, A | 1 |
| Alden, TD | 1 |
| Pardo, AC | 1 |
| Schertz, AR | 1 |
| Sarma, AK | 1 |
| Datar, S | 1 |
| Miller, PJ | 1 |
| Viderman, D | 1 |
| Sarria-Santamera, A | 1 |
| Bilotta, F | 1 |
| Morone, PJ | 1 |
| Yan, W | 1 |
| Adcock, J | 1 |
| Komalavilas, P | 1 |
| Mocco, J | 1 |
| Thompson, RC | 1 |
| Brophy, C | 1 |
| Cheung-Flynn, J | 1 |
| Mansoor, T | 1 |
| Alsarah, AA | 1 |
| Mousavi, H | 1 |
| Khader Eliyas, J | 1 |
| Girotra, T | 1 |
| Hussein, O | 1 |
| Wojcicki, KM | 1 |
| Evans, RL | 1 |
| Zwain, B | 1 |
| Deputy, S | 1 |
| García, L | 1 |
| Samuelsson, J | 1 |
| Sunila, M | 1 |
| Rentzos, A | 1 |
| Nilsson, D | 1 |
| Albanna, W | 2 |
| Weiss, M | 2 |
| Conzen, C | 2 |
| Clusmann, H | 2 |
| Schneider, T | 1 |
| Reinsch, M | 1 |
| Müller, M | 1 |
| Wiesmann, M | 1 |
| Höllig, A | 1 |
| Schubert, GA | 2 |
| Kumar, A | 2 |
| Phalak, M | 1 |
| Nasri, A | 1 |
| Mansour, M | 1 |
| Kacem, A | 1 |
| Zaouali, J | 1 |
| Mrissa, R | 1 |
| Wang, JL | 3 |
| Li, XN | 1 |
| Zhang, YH | 1 |
| Li, X | 1 |
| Yang, YL | 1 |
| Flessa, J | 1 |
| Lindenberg, N | 1 |
| Redel, A | 1 |
| Schneiker, A | 2 |
| Schuierer, G | 2 |
| Graf, B | 1 |
| Silbereisen, V | 1 |
| Nowack, MC | 1 |
| Wolf, H | 1 |
| Kurre, W | 1 |
| Duman, E | 1 |
| Karakoç, F | 1 |
| Pinar, HU | 1 |
| Dogan, R | 1 |
| Fırat, A | 1 |
| Yıldırım, E | 1 |
| Sánchez Arguiano, J | 1 |
| Hernández-Hernández, MA | 1 |
| Jáuregui Solórzano, RA | 1 |
| Maldonado-Vega, S | 1 |
| González Mandly, A | 1 |
| Burón Mediavilla, J | 1 |
| Diringer, MN | 2 |
| Zazulia, AR | 1 |
| Zhang, C | 1 |
| Zhao, S | 1 |
| Zang, Y | 1 |
| Zhao, W | 1 |
| Song, Q | 1 |
| Feng, S | 1 |
| Hu, L | 1 |
| Gu, F | 1 |
| Tallarico, RT | 1 |
| Pizzi, MA | 1 |
| Freeman, WD | 1 |
| Kraayvanger, L | 1 |
| Berlit, P | 1 |
| Albrecht, P | 1 |
| Hartung, HP | 1 |
| Kraemer, M | 1 |
| Adami, D | 1 |
| Berkefeld, J | 1 |
| Platz, J | 1 |
| Konczalla, J | 1 |
| Pfeilschifter, W | 1 |
| Weidauer, S | 1 |
| Wagner, M | 1 |
| Yi-Chou Wang, A | 1 |
| Paľa, A | 1 |
| Schneider, M | 1 |
| Brand, C | 1 |
| Pedro, MT | 1 |
| Özpeynirci, Y | 1 |
| Schmitz, B | 1 |
| Wirtz, CR | 1 |
| Kapapa, T | 1 |
| König, R | 1 |
| Braun, M | 1 |
| Kumpinsky, A | 1 |
| Nahas, SJ | 1 |
| Al-Mufti, F | 1 |
| Dodson, V | 1 |
| Wajswol, E | 1 |
| El-Ghanem, M | 1 |
| Alchaki, A | 1 |
| Nuoman, R | 1 |
| Thabet, A | 1 |
| Sutherland, A | 1 |
| Roychowdhury, S | 1 |
| Hidalgo, A | 1 |
| Gupta, G | 1 |
| Sriganesh, K | 1 |
| Venkataramaiah, S | 1 |
| Palaniswamy, SR | 1 |
| Simonato, D | 1 |
| Gabrieli, JD | 1 |
| Cester, G | 1 |
| Della Puppa, A | 1 |
| Causin, F | 1 |
| Silva, DP | 1 |
| Soares, MF | 1 |
| Almeida, V | 1 |
| Fonseca, AC | 1 |
| Qin, Y | 1 |
| Li, G | 1 |
| Sun, Z | 1 |
| Xu, X | 1 |
| Gu, J | 1 |
| Gao, F | 1 |
| Mitra, R | 1 |
| Dube, SK | 1 |
| Jain, V | 1 |
| Luo, F | 1 |
| Wu, L | 1 |
| Zhang, Z | 2 |
| Zhu, Z | 1 |
| Liu, Z | 1 |
| Guo, B | 1 |
| Li, N | 1 |
| Ju, J | 1 |
| Zhou, Q | 1 |
| Li, S | 1 |
| Yang, X | 1 |
| Mak, S | 1 |
| Han, Y | 1 |
| Sun, Y | 1 |
| Zhang, G | 1 |
| Pierscianek, D | 1 |
| Rölz, R | 1 |
| Darkwah Oppong, M | 1 |
| Kaier, K | 1 |
| Shah, M | 1 |
| Taschner, C | 1 |
| Mönninghoff, C | 1 |
| Urbach, H | 1 |
| Anand, S | 2 |
| Goel, G | 2 |
| Gupta, V | 2 |
| Larrosa-Campo, D | 1 |
| Ramon-Carbajo, C | 1 |
| Benavente-Fernandez, L | 1 |
| Alvarez-Escudero, R | 1 |
| Zeidan-Ramon, N | 1 |
| Calleja-Puerta, S | 1 |
| Pascual, J | 1 |
| Ponzetto, E | 1 |
| Vinetti, M | 1 |
| Grandin, C | 1 |
| Duprez, T | 1 |
| van Pesch, V | 1 |
| Deggouj, N | 1 |
| Lhommel, R | 1 |
| Hantson, P | 1 |
| Jaja, B | 1 |
| Cusimano, MD | 1 |
| Etminan, N | 2 |
| Hasan, D | 1 |
| Ilodigwe, D | 1 |
| Lantigua, H | 1 |
| Le Roux, P | 1 |
| Lo, B | 1 |
| Louffat-Olivares, A | 1 |
| Mayer, S | 1 |
| Molyneux, A | 1 |
| Quinn, A | 1 |
| Schweizer, TA | 1 |
| Schenk, T | 1 |
| Spears, J | 1 |
| Todd, M | 1 |
| Torner, J | 1 |
| Vergouwen, MD | 1 |
| Wong, GK | 1 |
| Singh, J | 1 |
| Rank, W | 1 |
| Afshari, FT | 1 |
| Fitzgerald, JJ | 1 |
| Higgins, JN | 1 |
| Garnett, MR | 1 |
| Fernandes, HM | 1 |
| Santarius, T | 1 |
| Rozen, TD | 1 |
| Beams, JL | 1 |
| Chowdhury, T | 1 |
| Schaller, B | 1 |
| Ott, S | 1 |
| Jedlicka, S | 1 |
| Wolf, S | 3 |
| Peter, M | 1 |
| Pudenz, C | 1 |
| Merker, P | 1 |
| Schürer, L | 2 |
| Lumenta, CB | 2 |
| Oyler, DR | 1 |
| Stump, SE | 1 |
| Cook, AM | 2 |
| Sherif, C | 1 |
| Wambacher, B | 1 |
| Loyoddin, M | 1 |
| Karaic, R | 1 |
| Krafft, P | 1 |
| Valentin, A | 1 |
| Tscholakoff, D | 1 |
| Kleinpeter, G | 1 |
| Heffren, J | 1 |
| McIntosh, AM | 1 |
| Reiter, PD | 1 |
| Hollingworth, M | 1 |
| Chen, PR | 1 |
| Goddard, AJ | 1 |
| Coulthard, A | 1 |
| Söderman, M | 1 |
| Bulsara, KR | 1 |
| Koskimäki, J | 1 |
| Tarkia, M | 1 |
| Ahtola-Sätilä, T | 1 |
| Saloranta, L | 1 |
| Simola, O | 1 |
| Forsback, AP | 1 |
| Laakso, A | 1 |
| Frantzén, J | 1 |
| Ehlert, A | 1 |
| Schmidt, C | 1 |
| Wölfer, J | 1 |
| Manthei, G | 1 |
| Jacobs, AH | 1 |
| Brüning, R | 1 |
| Heindel, W | 1 |
| Ringelstein, EB | 1 |
| Stummer, W | 1 |
| Pluta, RM | 1 |
| Hesselmann, V | 1 |
| Seker, F | 2 |
| Hesser, J | 2 |
| Brockmann, MA | 3 |
| Neumaier-Probst, E | 2 |
| Groden, C | 2 |
| Schubert, R | 2 |
| Brockmann, C | 2 |
| Proescholdt, MA | 1 |
| Hochreiter, A | 1 |
| Scheitzach, J | 1 |
| Bründl, E | 1 |
| Schödel, P | 1 |
| Brawanski, A | 1 |
| Yau, WY | 1 |
| Chu, E | 1 |
| Lai, N | 1 |
| Sandow, N | 1 |
| Diesing, D | 1 |
| Sarrafzadeh, A | 1 |
| Vajkoczy, P | 1 |
| Gölitz, P | 1 |
| Kaschka, I | 1 |
| Lang, S | 1 |
| Roessler, K | 1 |
| Knossalla, F | 1 |
| Doerfler, A | 1 |
| Hockel, K | 2 |
| Diedler, J | 2 |
| Steiner, J | 2 |
| Birkenhauer, U | 2 |
| Danz, S | 1 |
| Ernemann, U | 2 |
| Schuhmann, MU | 2 |
| Bashir, A | 1 |
| Andresen, M | 1 |
| Bartek, J | 1 |
| Cortsen, M | 1 |
| Eskesen, V | 1 |
| Wagner, A | 1 |
| Goel, R | 1 |
| Aggarwal, A | 1 |
| Salunke, P | 1 |
| Chhabra, R | 1 |
| Kerz, T | 2 |
| Boor, S | 2 |
| Ulrich, A | 1 |
| Beyer, C | 2 |
| Hechtner, M | 1 |
| Mueller-Forell, W | 1 |
| Fuest, M | 1 |
| Mueller, M | 1 |
| Vilser, W | 1 |
| Schmidt-Trucksäss, A | 1 |
| Hoellig, A | 1 |
| Seiz, M | 1 |
| Thomé, C | 1 |
| Kotliar, K | 1 |
| Aydin, HE | 1 |
| Bektur, NE | 1 |
| Ozbek, Z | 1 |
| Oner, S | 1 |
| Baycu, C | 1 |
| Kilic, FS | 1 |
| Francoeur, CL | 1 |
| Mayer, SA | 1 |
| Kulkarni, M | 1 |
| Chauhan, V | 1 |
| Shetty, S | 1 |
| von der Brelie, C | 1 |
| Doukas, A | 3 |
| Stopfer, A | 1 |
| Larsen, N | 1 |
| Mehdorn, M | 1 |
| Synowitz, M | 1 |
| Jansen, O | 3 |
| Hejčl, A | 1 |
| Cihlář, F | 1 |
| Smolka, V | 1 |
| Vachata, P | 1 |
| Bartoš, R | 1 |
| Procházka, J | 1 |
| Cihlář, J | 1 |
| Sameš, M | 1 |
| Rustemi, O | 1 |
| Beseoglu, K | 5 |
| Turowski, B | 4 |
| Devlin, MM | 1 |
| Kronvall, E | 1 |
| Undrén, P | 1 |
| Romner, B | 2 |
| Säveland, H | 1 |
| Cronqvist, M | 1 |
| Nilsson, OG | 1 |
| Conti, A | 1 |
| Angileri, FF | 1 |
| Longo, M | 1 |
| Pitrone, A | 1 |
| Granata, F | 1 |
| La Rosa, G | 1 |
| Deshaies, EM | 1 |
| Boulos, AS | 1 |
| Drazin, D | 1 |
| Popp, AJ | 1 |
| Yin, YH | 2 |
| Wang, F | 2 |
| Pan, YH | 1 |
| Luo, QZ | 1 |
| Jiang, JY | 2 |
| Elstner, M | 1 |
| Linn, J | 2 |
| Müller-Schunk, S | 1 |
| Straube, A | 3 |
| Koskinen, LO | 1 |
| Olivecrona, M | 1 |
| Rodling-Wahlström, M | 1 |
| Naredi, S | 1 |
| Beccia, M | 1 |
| Ceschin, V | 1 |
| Bozzao, A | 1 |
| Romano, A | 1 |
| Biraschi, F | 1 |
| Fantozzi, LM | 1 |
| Rasura, M | 1 |
| Eicker, S | 3 |
| Rapp, M | 1 |
| Perrin, J | 2 |
| Nawatny, J | 1 |
| Sommer, C | 2 |
| Jia, F | 1 |
| Pei, SL | 1 |
| Meng, YN | 1 |
| Hu, ZY | 1 |
| Mo, YC | 2 |
| Zhou, LP | 1 |
| Chen, WJ | 1 |
| Behr, J | 1 |
| Ducros, A | 1 |
| Bousser, MG | 1 |
| Bilginer, B | 2 |
| Onal, MB | 5 |
| Narin, F | 2 |
| Soylemezoglu, F | 1 |
| Ziyal, IM | 1 |
| Ozgen, T | 1 |
| Martin, H | 1 |
| Landscheidt, JF | 1 |
| Rodiek, SO | 2 |
| Desruisseaux, MS | 1 |
| Machado, FS | 1 |
| Weiss, LM | 1 |
| Tanowitz, HB | 1 |
| Golightly, LM | 1 |
| Cabrales, P | 1 |
| Zanini, GM | 1 |
| Meays, D | 1 |
| Frangos, JA | 1 |
| Carvalho, LJ | 1 |
| Gul, S | 1 |
| Bahadir, B | 1 |
| Hanci, V | 1 |
| Acikgoz, S | 1 |
| Bektas, S | 1 |
| Ugurbas, E | 1 |
| Ankarali, H | 1 |
| Kalayci, M | 1 |
| Acikgoz, B | 1 |
| Pasternak, JJ | 1 |
| Lanier, WL | 1 |
| Weant, KA | 1 |
| Ramsey, CN | 1 |
| Webb, AJ | 1 |
| Gillies, MJ | 1 |
| Cadoux-Hudson, TA | 1 |
| Petridis, AK | 2 |
| Barth, H | 2 |
| Mehdorn, HM | 2 |
| Naidech, AM | 1 |
| Liebling, SM | 1 |
| Duran, IM | 1 |
| Ault, ML | 1 |
| Civelek, E | 4 |
| Kircelli, A | 4 |
| Solmaz, I | 4 |
| Ugurel, S | 2 |
| Isikay, I | 1 |
| Yakupoglu, H | 1 |
| Tehli, O | 1 |
| Izci, Y | 2 |
| Erdogan, E | 2 |
| Gonul, E | 3 |
| Temiz, C | 1 |
| Secer, HI | 1 |
| Ongoru, O | 1 |
| Sun, BL | 1 |
| Xia, ZL | 1 |
| Yang, MF | 1 |
| Fesl, G | 1 |
| Ottomeyer, C | 1 |
| Dichgans, M | 1 |
| Bruckmann, H | 1 |
| Pfefferkorn, T | 1 |
| Musahl, C | 1 |
| Vajda, Z | 1 |
| Coburger, J | 1 |
| Hopf, N | 1 |
| Mani, BK | 1 |
| Brueggemann, LI | 1 |
| Cribbs, LL | 1 |
| Byron, KL | 1 |
| Yu, JM | 1 |
| Liang, DD | 1 |
| Tao, F | 1 |
| Geng, WJ | 1 |
| Chadha, PS | 1 |
| Greenwood, IA | 1 |
| Zhong, XZ | 1 |
| Cole, WC | 1 |
| Samaniego, EA | 1 |
| Dabus, G | 1 |
| Fuentes, K | 1 |
| Linfante, I | 1 |
| Maslehaty, H | 1 |
| Cho, WS | 1 |
| Kang, HS | 1 |
| Kim, JE | 1 |
| Kwon, OK | 1 |
| Oh, CW | 1 |
| Son, YJ | 1 |
| Know, BJ | 1 |
| Jung, C | 1 |
| Hang, MH | 1 |
| Han, YY | 1 |
| Gui, W | 1 |
| Zhu, J | 1 |
| Liu, YM | 1 |
| Wang, K | 1 |
| Zhao, J | 2 |
| Zhou, D | 2 |
| Guo, J | 2 |
| Ren, Z | 2 |
| Zhou, L | 2 |
| Wang, S | 3 |
| Zhang, Y | 1 |
| Xu, B | 3 |
| Zhao, K | 1 |
| Wang, R | 2 |
| Mao, Y | 1 |
| Zhang, X | 1 |
| Welschehold, S | 1 |
| Schuessler, A | 1 |
| Oertel, J | 1 |
| Escribano, AB | 1 |
| Peña, E | 1 |
| Barbosa, A | 1 |
| Fernández, C | 1 |
| Cook, DJ | 1 |
| Kan, S | 1 |
| Ai, J | 1 |
| Kasuya, H | 1 |
| Zhao, WJ | 1 |
| Wu, C | 1 |
| Koenig, MA | 1 |
| Leung, M | 1 |
| Tice, T | 1 |
| Aburto-Murrieta, Y | 1 |
| Marquez-Romero, JM | 1 |
| Bonifacio-Delgadillo, D | 1 |
| López, I | 1 |
| Hernández-Curiel, B | 1 |
| Ioannidis, I | 1 |
| Nasis, N | 1 |
| Agianniotaki, A | 1 |
| Katsouda, E | 1 |
| Andreou, A | 1 |
| Kamp, MA | 1 |
| Heiroth, HJ | 1 |
| Bege, N | 2 |
| Macht, S | 1 |
| Frauenknecht, K | 1 |
| Kissel, T | 2 |
| Ko, CN | 1 |
| Lee, IW | 1 |
| Cho, SY | 1 |
| Lee, SH | 1 |
| Park, SU | 1 |
| Koh, JS | 1 |
| Park, JM | 1 |
| Kim, GK | 1 |
| Bae, HS | 1 |
| Chalouhi, N | 1 |
| Jabbour, P | 1 |
| Ibrahim, I | 1 |
| Starke, RM | 1 |
| Younes, P | 1 |
| El Hage, G | 1 |
| Samaha, E | 1 |
| Renette, T | 1 |
| Endres, T | 1 |
| Beck-Broichsitter, M | 1 |
| Dorsch, NW | 1 |
| Xiao, X | 1 |
| Guo, X | 1 |
| Wang, D | 1 |
| Xue, G | 1 |
| Nowak, DA | 1 |
| Henneken, S | 1 |
| Zinner, J | 1 |
| Schreiner, R | 1 |
| Fuchs, HH | 1 |
| Topka, H | 1 |
| Rosengart, A | 1 |
| Huo, D | 1 |
| Karrison, T | 1 |
| Liao, YC | 2 |
| Fuh, JL | 2 |
| Lirng, JF | 2 |
| Lu, SR | 2 |
| Wu, ZA | 1 |
| Wang, SJ | 2 |
| Harscher, S | 1 |
| Witte, OW | 1 |
| Möller, U | 1 |
| Bloos, G | 1 |
| Pfleiderer, SO | 1 |
| Terborg, C | 1 |
| LeStrange, DG | 1 |
| Han, RQ | 1 |
| Wang, BG | 1 |
| Li, SR | 1 |
| Wang, EZ | 1 |
| Liu, W | 1 |
| Zhao, JZ | 1 |
| Hui, C | 1 |
| Lau, KP | 1 |
| Sakowitz, OW | 1 |
| Unterberg, AW | 1 |
| Biondi, A | 1 |
| Le Jean, L | 1 |
| Puybasset, L | 2 |
| Laslo, AM | 1 |
| Eastwood, JD | 1 |
| Chen, FX | 1 |
| Lee, TY | 1 |
| Inzitari, D | 1 |
| Poggesi, A | 1 |
| Schmid-Elsaesser, R | 1 |
| Kunz, M | 1 |
| Zausinger, S | 1 |
| Prueckner, S | 1 |
| Briegel, J | 1 |
| Plendl, H | 1 |
| Bruening, R | 1 |
| Mesis, RG | 1 |
| Wang, H | 1 |
| Lombard, FW | 1 |
| Yates, R | 1 |
| Vitek, MP | 1 |
| Borel, CO | 1 |
| Warner, DS | 1 |
| Laskowitz, DT | 1 |
| van den Bergh, WM | 1 |
| Mees, SM | 1 |
| Rinkel, GJ | 1 |
| Jiang, WJ | 1 |
| Du, B | 1 |
| Leung, TW | 1 |
| Xu, XT | 1 |
| Jin, M | 1 |
| Dong, KH | 1 |
| Mehta, AK | 1 |
| Yadav, KS | 1 |
| Sawant, KK | 1 |
| Keyrouz, SG | 1 |
| Tavernier, B | 1 |
| Decamps, F | 1 |
| Vega, E | 1 |
| Poidevin, P | 1 |
| Verdin, M | 1 |
| Riegel, B | 1 |
| Abdennour, L | 1 |
| Lejean, L | 1 |
| Bonneville, F | 1 |
| Boch, AL | 1 |
| Oran, I | 1 |
| Cinar, C | 1 |
| Neuschmelting, V | 1 |
| Graupner, T | 1 |
| Jakob, SM | 1 |
| Fandino, J | 1 |
| Kamath, S | 1 |
| Gadhinglajkar, SV | 1 |
| Yong, M | 1 |
| Karinen, P | 1 |
| Koivukangas, P | 1 |
| Ohinmaa, A | 1 |
| Koivukangas, J | 1 |
| Ohman, J | 1 |
| Matula, C | 2 |
| Egge, A | 1 |
| Waterloo, K | 1 |
| Sjøholm, H | 1 |
| Solberg, T | 1 |
| Ingebrigtsen, T | 1 |
| Corsten, L | 1 |
| Raja, A | 1 |
| Guppy, K | 1 |
| Roitberg, B | 1 |
| Misra, M | 1 |
| Alp, MS | 1 |
| Charbel, F | 1 |
| Debrun, G | 1 |
| Ausman, J | 1 |
| Schoeggl, A | 1 |
| Stachura, K | 1 |
| Danilewicz, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Inter- and Intra-Observer Variability in Transcranial Doppler (TCD) Technique in Neurocritical Care Patients[NCT04583163] | 12 participants (Anticipated) | Observational | 2020-09-22 | Recruiting | |||
| Cerebral Aneurysms: a Retrospective Study on the Experience in Our Hospital With a Comparative Analysis Between the Different Techniques Used in Its Treatment[NCT04792944] | 247 participants (Actual) | Observational | 2007-01-01 | Completed | |||
| Effect of Superior Cervical Sympathetic Block Versus Stellate Ganglion Block to Treat Cerebral Vasospasm in Patients With Refractory Post-traumatic Subarachnoid Hemorrhage.[NCT06134583] | 60 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | |||
| Neuroprotective Effect of Dapsone in Patients With Aneurysmal Subarachnoid Hemorrhage: Prospective, Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial[NCT05131295] | Phase 3 | 49 participants (Actual) | Interventional | 2007-09-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
30 reviews available for nimodipine and Angiospasm, Intracranial
| Article | Year |
|---|---|
Lessons Learned from Phase II and Phase III Trials Investigating Therapeutic Agents for Cerebral Ischemia Associated with Aneurysmal Subarachnoid Hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III | 2022 |
Therapeutic Approaches for Cerebrovascular Dysfunction After Aneurysmal Subarachnoid Hemorrhage: An Update and Future Perspectives.
Topics: Brain Injuries; Brain Ischemia; Cerebral Infarction; Humans; Nimodipine; Quality of Life; Subarachno | 2022 |
Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis of Randomized Trials.
Topics: Adult; Brain Ischemia; Cilostazol; Humans; Magnesium; Morbidity; Network Meta-Analysis; Nicardipine; | 2022 |
A Comparison Between Enteral and Intravenous Nimodipine in Subarachnoid Hemorrhage: A Systematic Review and Network Meta-Analysis.
Topics: Brain Ischemia; Cerebral Infarction; Humans; Network Meta-Analysis; Nimodipine; Randomized Controlle | 2022 |
Delayed cerebral ischemia after meningioma resection: Literature review and illustrative case.
Topics: Brain Ischemia; Humans; Meningeal Neoplasms; Meningioma; Middle Aged; Nimodipine; Paresis; Platelet | 2022 |
Cerebral Vasospasm: Practical Review of Diagnosis and Management.
Topics: Brain Injuries; Humans; Nimodipine; Subarachnoid Hemorrhage; Treatment Outcome; Vasospasm, Intracran | 2023 |
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review.
Topics: Adult; Albumins; Calcium Channel Blockers; Epstein-Barr Virus Nuclear Antigens; Headache; Humans; Im | 2022 |
Verapamil in the treatment of reversible cerebral vasoconstriction syndrome: A systematic review.
Topics: Cerebrovascular Disorders; Humans; Nimodipine; Vasoconstriction; Vasospasm, Intracranial; Verapamil | 2023 |
Cortical Spreading Depolarization and Delayed Cerebral Ischemia; Rethinking Secondary Neurological Injury in Subarachnoid Hemorrhage.
Topics: Autonomic Nervous System Diseases; Brain; Brain Ischemia; Cerebral Infarction; Humans; Nimodipine; S | 2023 |
Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Double-Blind Method; Humans; Nimodipine; Ra | 2021 |
Side effects of continuous intra-arterial infusion of nimodipine for management of resistant cerebral vasospasm in subarachnoid hemorrhage patients: A systematic review.
Topics: Humans; Infusions, Intra-Arterial; Nimodipine; Retrospective Studies; Subarachnoid Hemorrhage; Vasos | 2021 |
Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit.
Topics: Calcium Channel Blockers; Delayed-Action Preparations; Humans; Intensive Care Units; Intracranial An | 2017 |
Investigational drugs for vasospasm after subarachnoid hemorrhage.
Topics: Animals; Brain Ischemia; Drug Design; Drugs, Investigational; Humans; Neuroprotective Agents; Nimodi | 2018 |
Coadjuvant Treatment of Vasospasm in Ruptured Unsecured Cerebral Aneurysms with Aggressive Angioplasty, Intra-Arterial Nimodipine, and Aneurysm Embolization.
Topics: Adult; Aged; Aneurysm, Ruptured; Angioplasty; Combined Modality Therapy; Embolization, Therapeutic; | 2018 |
Bath-Related Headache.
Topics: Animals; Antihypertensive Agents; Headache; Headache Disorders, Primary; Humans; Nimodipine; Vasocon | 2018 |
SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.
Topics: Antioxidants; Brain Infarction; Calcium Channel Blockers; Critical Care; Dioxanes; Drug Therapy, Com | 2013 |
Management of delayed cerebral ischemia after subarachnoid hemorrhage.
Topics: Brain Ischemia; Calcium Channel Blockers; Disease Management; Humans; Hyponatremia; Hypotension; Hyp | 2016 |
Evidence-based pharmacotherapy for cerebral vasospasm.
Topics: Animals; Cardiovascular Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxymethylglutaryl-C | 2009 |
Reversible cerebral vasoconstriction syndrome.
Topics: Age of Onset; Cerebral Angiography; Female; Humans; Male; Nimodipine; Sex Factors; Stroke; Subarachn | 2009 |
Neuroanesthesiology update.
Topics: Anesthesia; Anesthesiology; Animals; Anticonvulsants; Brain; Calcium Channel Blockers; Electroenceph | 2010 |
Role of intraarterial therapy for cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhi | 2010 |
Management of delayed cerebral ischemia after subarachnoid hemorrhage.
Topics: Angioplasty, Balloon; Brain Ischemia; Calcium Channel Blockers; Cardiovascular Agents; Cerebral Angi | 2012 |
Intracranial drug delivery for subarachnoid hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug De | 2012 |
Therapeutic approaches to vasospasm in subarachnoid hemorrhage.
Topics: Angioplasty, Balloon; Blood Volume; Calcium Channel Blockers; Fibrinolytic Agents; Fluid Therapy; He | 2002 |
Detecting and treating microvascular ischemia after subarachnoid hemorrhage.
Topics: Antihypertensive Agents; Cerebrovascular Circulation; Hemodilution; Humans; Hypoxia-Ischemia, Brain; | 2006 |
Calcium channel blockers and stroke.
Topics: Aged; Antihypertensive Agents; Atherosclerosis; Calcium Channel Blockers; Dementia, Vascular; Humans | 2005 |
Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage.
Topics: Angioplasty, Balloon; Calcium Channel Blockers; Cerebral Angiography; Endothelin-1; Humans; Hydroxym | 2007 |
Subarachnoid hemorrhage and cerebral vasospasm--facts and perspectives.
Topics: Adolescent; Adult; Age Factors; Austria; Calcium Channel Blockers; Drug Therapy, Combination; Female | 2000 |
Cerebral protection before, during and after neurosurgical procedures.
Topics: Amino Acids; Brain Damage, Chronic; Calcium Channel Blockers; Clinical Trials as Topic; Cognition Di | 2000 |
[Cerebral vasospasm after subarachnoid hemorrhage. Current possibilities of prevention and treatment].
Topics: Aneurysm, Ruptured; Humans; Neuroprotective Agents; Nimodipine; Pregnatrienes; Subarachnoid Hemorrha | 2002 |
17 trials available for nimodipine and Angiospasm, Intracranial
| Article | Year |
|---|---|
Clinical Outcome in Cerebral Vasospasm Patients Treated with and without Intra-Arterial Nimodipine Infusion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Humans; Middle Aged; Nimodipine; Prospective Studies; Re | 2022 |
Effect of Locally Delivered Nimodipine Microparticles on Spreading Depolarization in Aneurysmal Subarachnoid Hemorrhage.
Topics: Brain; Brain Ischemia; Electrocorticography; Humans; Nimodipine; Subarachnoid Hemorrhage; Vasospasm, | 2021 |
Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Topics: Adult; Brain Ischemia; Cerebral Infarction; Double-Blind Method; Drug Therapy, Combination; Female; | 2018 |
Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Cohort Studies; Drug Administration Schedule; Feasibility Studies; Female; Humans; Infusions, | 2016 |
Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration.
Topics: Administration, Oral; Aged; Calcium Channel Blockers; Endpoint Determination; Female; Follow-Up Stud | 2009 |
A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
Topics: Adult; Aged; Calcium Channel Blockers; Combined Modality Therapy; Female; Humans; Male; Middle Aged; | 2009 |
Continuous intra-arterial infusion of nimodipine at the onset of resistant vasospasm in aneurysmal subarachnoidal haemorrhage. Technical report.
Topics: Antihypertensive Agents; Coronary Angiography; Female; Humans; Infusions, Intra-Arterial; Male; Midd | 2011 |
Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Aged; Brain Ischemia; Calcium Channel Blockers | 2011 |
Mechanism and treatment principle for cerebral vessel spasm caused by concussion.
Topics: Adolescent; Adult; Aged; Blood Flow Velocity; Brain Concussion; Cerebral Arteries; Cerebrovascular C | 2002 |
Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Combined Modality Therapy; Double-Blind Method; Drug Therapy, Combination; Female; Huma | 2003 |
Nimodipine for treatment of primary thunderclap headache.
Topics: Administration, Oral; Adult; Aged; Brain; Cerebral Angiography; Female; Headache; Humans; Injections | 2004 |
[The effect of intraoperative continuous nimodipine infusion on cerebral vasospasm during intracranial aneurysm surgery].
Topics: Adult; Aged; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Intravenous; Female; Huma | 2004 |
Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Topics: Adult; Aged; Brain Ischemia; Calcium Channel Blockers; Cerebral Angiography; Cerebral Infarction; Fe | 2006 |
Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Brain Ischemia; Female; Humans; Male; Middle A | 2006 |
Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.
Topics: Adult; Aged; Aged, 80 and over; Cerebrovascular Circulation; Female; Humans; Injections, Intra-Arter | 2008 |
Cost-effectiveness analysis of nimodipine treatment after aneurysmal subarachnoid hemorrhage and surgery.
Topics: Adolescent; Adult; Aged; Aneurysm, Ruptured; Combined Modality Therapy; Cost-Benefit Analysis; Doubl | 1999 |
Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study.
Topics: Aged; Brain; Brain Ischemia; Cognition Disorders; Echoencephalography; Female; Fluid Therapy; Follow | 2001 |
142 other studies available for nimodipine and Angiospasm, Intracranial
| Article | Year |
|---|---|
Radiation exposure in the intra-arterial nimodipine therapy of subarachnoid hemorrhage related cerebral vasospasm.
Topics: Humans; Nimodipine; Radiation Exposure; Retrospective Studies; Subarachnoid Hemorrhage; Treatment Ou | 2022 |
Influence of nimodipine combined with ulinastatin on neurological function and inflammatory reaction in patients with cerebral vasospasm after subarachnoid hemorrhage.
Topics: Adult; Blood Flow Velocity; Cerebral Arteries; Drug Therapy, Combination; Female; Glycoproteins; Hum | 2021 |
Early cisternal fibrinolysis is more effective than rescue spasmolysis for the prevention of delayed infarction after subarachnoid haemorrhage.
Topics: Cerebral Infarction; Fibrinolysis; Humans; Nimodipine; Parasympatholytics; Retrospective Studies; Su | 2022 |
Continuous intra-arterial nimodipine infusion as rescue treatment of severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Humans; Infusions, Intra-Arterial; Nimodipine; Quality of Life; Retrospective Studies; Subarachnoid | 2022 |
Large practice variations in diagnosis and treatment of delayed cerebral ischemia after subarachnoid hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Humans; Nimodipine; Subarachnoid Hemorrhage; Vasospasm, Intracr | 2022 |
Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Brain Ischemia; Cerebral Infarction; Hemodynamics; Humans; Hypertension; Milrinone; Nimodipine; Nore | 2022 |
Analysis of Angiographic Treatment Response to Intra-Arterial Nimodipine Bolus Injection in Patients with Medically Refractory Cerebral Vasospasm After Spontaneous Subarachnoid Hemorrhage.
Topics: Aged; Brain Ischemia; Cerebral Infarction; Humans; Infarction; Nimodipine; Retrospective Studies; Su | 2022 |
Role of Nimodipine and Milrinone in Delayed Cerebral Ischemia.
Topics: Brain Ischemia; Cerebral Infarction; Humans; Milrinone; Nimodipine; Subarachnoid Hemorrhage; Vasospa | 2022 |
Intracranial stenting as a bail-out option for posthemorrhagic cerebral vasospasm: a single-center experience with long-term follow-up.
Topics: Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis Implantation; Endovascular Procedures; Eptifibat | 2022 |
Vasodilatory effects of tadalafil in an animal model of cerebral vasospasm: Comparative analysis with oral nimodipine.
Topics: Animals; Humans; Models, Animal; Nimodipine; Rabbits; Subarachnoid Hemorrhage; Tadalafil; Treatment | 2023 |
Evaluation of DeGIR registry data on endovascular treatment of cerebral vasospasm in Germany 2018-2021: an overview of the current care situation.
Topics: Endovascular Procedures; Female; Humans; Male; Nimodipine; Papaverine; Retrospective Studies; Routin | 2023 |
Mass spectrometry-based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage.
Topics: Adult; Aged; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Female; Glutamic Acid; | 2020 |
May levosimendan be safe and effective in refractory vasospasm despite adequate treatment with repeated angiography and milrinone infusion after subarachnoid haemorrhage?
Topics: Aneurysm, Ruptured; Cardiotonic Agents; Cerebral Angiography; Cerebrospinal Fluid Leak; Computed Tom | 2019 |
Reversible Cerebral Vasoconstriction Syndrome Responsive to Intravenous Milrinone.
Topics: Adult; Angiography, Digital Subtraction; Aphasia, Broca; Brain Edema; Cerebral Hemorrhage; Computed | 2020 |
Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience.
Topics: Adult; Angioplasty, Balloon; Brain Infarction; Brain Ischemia; Cerebral Angiography; Endovascular Pr | 2020 |
Symptomatic Cerebral Vasospasm after Spontaneous Subarachnoid Hemorrhage: Comparison of Single and Multiple Intra-arterial Treatment with Respect to the Functional Outcome.
Topics: Aged; Angioplasty; Female; Humans; Male; Middle Aged; Nimodipine; Prognosis; Retrospective Studies; | 2020 |
Impact of Stereotactic Ventriculocisternostomy on Delayed Cerebral Infarction and Outcome After Subarachnoid Hemorrhage.
Topics: Aged; Aneurysm, Ruptured; Cerebral Infarction; Female; Fibrinolytic Agents; Humans; Intracranial Ane | 2020 |
Reversible Cerebral Vasoconstriction Syndrome: Perhaps Not So Reversible?
Topics: Adult; Computed Tomography Angiography; Female; Headache Disorders, Primary; Humans; Nimodipine; Vas | 2020 |
Significant reduction of vascular reactivity with dantrolene and nimodipine in diabetic rats: a potential approach to cerebral vasospasm management in diabetes.
Topics: Acetylcholine; Animals; Dantrolene; Diabetes Mellitus, Experimental; Dose-Response Relationship, Dru | 2020 |
Effects of nimodipine combined with betahistine on CRP and other inflammatory cytokines and vascular endothelial function in patients with hypertensive cerebral vasospasm.
Topics: Aged; Antihypertensive Agents; Betahistine; C-Reactive Protein; Cytokines; Female; Humans; Hypertens | 2020 |
The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage.
Topics: Administration, Oral; Adult; Aged; Brain Ischemia; Drug Administration Schedule; Enteral Nutrition; | 2020 |
Early strategy of scepter XC balloon angioplasty and simultaneous Nimodipine infusion for vasospasm following ruptured aneurysm.
Topics: Adult; Aged; Aneurysm, Ruptured; Angioplasty, Balloon; Computed Tomography Angiography; Female; Huma | 2020 |
Large Subcortical Intracerebral Hemorrhage Because of Reversible Cerebral Vasoconstriction Syndrome: A Case Study.
Topics: Adult; Aneurysm, False; Cerebral Angiography; Cerebral Hemorrhage; Computed Tomography Angiography; | 2020 |
Use of Nimodipine in a Neonate With Cerebral Vasospasm With Delayed Ischemia From Subarachnoid Hemorrhage in the Posterior Fossa.
Topics: Angiography, Digital Subtraction; Brain Ischemia; Cerebral Angiography; Cranial Fossa, Posterior; Hu | 2020 |
Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion.
Topics: Antacids; Brain; Calcium Carbonate; Calcium Channel Blockers; Cerebral Angiography; Computed Tomogra | 2021 |
Vasorelaxing cell permeant phosphopeptide mimetics for subarachnoid hemorrhage.
Topics: Animals; Cell Adhesion Molecules; Cyclic GMP-Dependent Protein Kinases; Down-Regulation; Drug Design | 2021 |
COVID-19 Associated Reversible Cerebral Vasoconstriction Syndrome Successfully Treated with Nimodipine and Aspirin.
Topics: Adult; Aspirin; Cerebral Arteries; COVID-19; Female; Humans; Nimodipine; Syndrome; Treatment Outcome | 2021 |
Micturition induced primary thunderclap headache in an 11-year-old with response to nimodipine.
Topics: Child; Headache Disorders, Primary; Humans; Nimodipine; Urination; Vasospasm, Intracranial | 2021 |
The combination of dantrolene and nimodipine effectively reduces 5-HT-induced vasospasms in diabetic rats.
Topics: Animals; Calcium Channel Blockers; Dantrolene; Diabetes Mellitus, Experimental; Drug Therapy, Combin | 2021 |
Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid haemorrhage - neurological and radiological outcome.
Topics: Humans; Nimodipine; Retrospective Studies; Subarachnoid Hemorrhage; Treatment Outcome; Vasodilator A | 2022 |
Systemic and Cerebral Concentration of Nimodipine During Established and Experimental Vasospasm Treatment.
Topics: Aged; Cerebral Cortex; Chromatography, Liquid; Dose-Response Relationship, Drug; Female; Humans; Mal | 2017 |
Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid hemorrhage?
Topics: Humans; Nimodipine; Subarachnoid Hemorrhage; Vasodilator Agents; Vasospasm, Intracranial | 2017 |
Reversible cerebral vasoconstriction syndrome and antivitamin K anticoagulation: challenges of an unusual association.
Topics: 4-Hydroxycoumarins; Adult; Anticoagulants; Constriction, Pathologic; Female; Headache Disorders, Pri | 2017 |
Evaluation function of transcranial two-dimensional and color Doppler ultrasonography (TCCS) for patients with different degrees of cerebral vasospasm before and after the nimodipine treatment.
Topics: Adult; Aged; Blood Flow Velocity; Female; Hemodynamics; Humans; Male; Middle Aged; Middle Cerebral A | 2017 |
Side Effects of Long-Term Continuous Intra-arterial Nimodipine Infusion in Patients with Severe Refractory Cerebral Vasospasm after Subarachnoid Hemorrhage.
Topics: Adult; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infusions, Intra-Arterial; M | 2018 |
Topics: Adult; Cerebral Angiography; Computed Tomography Angiography; Diagnosis, Differential; Headache Diso | 2018 |
Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
Topics: Angiography, Digital Subtraction; Cerebral Angiography; Computed Tomography Angiography; Drug Therap | 2017 |
Stellate ganglion block as rescue therapy in refractory vasospasm after subarachnoid hemorrhage.
Topics: Anesthetics, Local; Aneurysm, Ruptured; Arm; Bupivacaine; Humans; Intracranial Aneurysm; Middle Aged | 2019 |
Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis?
Topics: Adult; Angiography; Cell Count; Cerebrospinal Fluid; Diagnosis, Differential; Female; Headache; Huma | 2018 |
Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk?
Topics: Adult; Aged; Angioplasty; Aortic Dissection; Cerebral Infarction; Combined Modality Therapy; Female; | 2019 |
The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation.
Topics: Aged; Brain Ischemia; Calcium Channel Blockers; Carotid Arteries; Feasibility Studies; Female; Human | 2019 |
Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome
Topics: Angioplasty; Calcium Channel Blockers; Drug Resistance; Female; Humans; Infusions, Intra-Arterial; M | 2018 |
Effect of Intra-arterial Nimodipine on Cerebral Oxygen Saturation and Systemic Hemodynamic Indices in Patients With Cerebral Vasospasm: A Prospective Cohort Study.
Topics: Brain; Cohort Studies; Female; Hemodynamics; Humans; Male; Middle Aged; Nimodipine; Oxygen; Prospect | 2020 |
Intracranial stenting after tumor exeresis complicated by delayed kinking of the middle cerebral artery.
Topics: Aged; Cerebral Revascularization; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Cerebral Art | 2019 |
A novel rescue therapy for cerebral vasospasm: Cisternal Nimodipine application via stereotactic catheter ventriculocisternostomy.
Topics: Catheters; Cerebral Infarction; Female; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Nimod | 2019 |
Chronic headache with vasospasm treated with nimodipine.
Topics: Female; Headache Disorders; Humans; Magnetic Resonance Imaging; Middle Aged; Nimodipine; Ultrasonogr | 2019 |
Comparison of the effects of nimodipine and deferoxamine on brain injury in rat with subarachnoid hemorrhage.
Topics: Animals; Atrophy; Cognitive Dysfunction; Deferoxamine; Disease Models, Animal; Ferritins; Male; Maze | 2019 |
Isolated diastolic hypotension: A unique complication of intra-arterial nimodipine infusion!!
Topics: Aged; Angiography, Digital Subtraction; Anterior Cerebral Artery; Blood Pressure; Diastole; Electroc | 2020 |
The dual-functional memantine nitrate MN-08 alleviates cerebral vasospasm and brain injury in experimental subarachnoid haemorrhage models.
Topics: Animals; Brain Injuries; Disease Models, Animal; Dose-Response Relationship, Drug; HEK293 Cells; Hum | 2019 |
Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: More is more.
Topics: Adult; Aged; Angioplasty, Balloon; Arterial Pressure; Brain Ischemia; Endovascular Procedures; Femal | 2019 |
Continuous intra-arterial dilatation with nimodipine and milrinone for refractory cerebral vasospasm.
Topics: Angioplasty, Balloon; Cerebral Angiography; Dilatation; Drug Resistance; Female; Humans; Infusions, | 2014 |
[Diagnosis of stroke due to cocaine and its complications].
Topics: Adult; Aphasia; Cerebrovascular Circulation; Cocaine; Cocaine-Related Disorders; Crack Cocaine; Hemi | 2013 |
In brief: nimodipine oral solution (Nymalize).
Topics: Administration, Oral; Aneurysm, Ruptured; Calcium Channel Blockers; Drug Approval; Humans; Intracran | 2013 |
Partly reversible central auditory dysfunction induced by cerebral vasospasm after subarachnoid hemorrhage.
Topics: Angioplasty; Auditory Diseases, Central; Female; Humans; Middle Aged; Middle Cerebral Artery; Nimodi | 2013 |
Using nimodipine for patients with aneurysmal subarachnoid hemorrhage.
Topics: Calcium Channel Blockers; Humans; Intracranial Aneurysm; Nimodipine; Practice Guidelines as Topic; R | 2014 |
Diffuse cerebral vasospasm following resection of a hypoglossal schwannoma in a child.
Topics: Cerebral Angiography; Child; Cranial Nerve Neoplasms; Female; Humans; Milrinone; Neurilemmoma; Nimod | 2014 |
New daily persistent headache with a thunderclap headache onset and complete response to nimodipine (a new distinct subtype of NDPH).
Topics: Analgesics; Brain; Headache; Humans; Nimodipine; Vasospasm, Intracranial | 2013 |
The need for development of protocol for managing refractory cerebral vasospasm.
Topics: Female; Humans; Milrinone; Nimodipine; Vasodilator Agents; Vasospasm, Intracranial | 2014 |
Protocol for vasospasm.
Topics: Blood Pressure; Clinical Protocols; Humans; Neurosurgical Procedures; Nimodipine; Vasodilator Agents | 2014 |
Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Cerebrovascular Circulation; Female; Glasgow Outcome Scale; Humans; Infusions, Intra-Ar | 2014 |
Accuracy of nimodipine gel extraction.
Topics: Brain Ischemia; Calcium Channel Blockers; Drug Compounding; Humans; Nimodipine; Vasospasm, Intracran | 2015 |
Repeated combined endovascular therapy with milrinone and nimodipine for the treatment of severe vasospasm: preliminary results.
Topics: Adult; Combined Modality Therapy; Endovascular Procedures; Female; Follow-Up Studies; Humans; Male; | 2015 |
Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
Topics: Adolescent; Cerebral Angiography; Child; Child, Preschool; Female; Humans; Male; Nimodipine; Retrosp | 2015 |
Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia.
Topics: Adult; Australasia; Brain Ischemia; Disease Management; Endovascular Procedures; Europe; Female; Hea | 2015 |
Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model.
Topics: Animals; Delayed-Action Preparations; Disease Models, Animal; Dogs; Intracranial Aneurysm; Nimodipin | 2015 |
Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Infarction; Brain Ischemia; Drug Therapy, Combinat | 2016 |
Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm.
Topics: Computer Simulation; Humans; Injections, Intra-Arterial; Metabolic Clearance Rate; Models, Cardiovas | 2017 |
Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
Topics: Adult; Calcium Channel Blockers; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nimod | 2015 |
Cannabis, serotonergic drug use and stroke in a 50-year-old woman.
Topics: Cannabis; Cerebral Angiography; Cognition Disorders; Female; Headache Disorders, Primary; Humans; Ma | 2015 |
Nimodipine Dose Reductions in the Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Calcium Channel Blockers; Cerebral Infarction; Female; Humans; Intracranial Aneurysm; Male; M | 2016 |
Real-Time, In Vivo Monitoring, and Quantitative Assessment of Intra-Arterial Vasospasm Therapy.
Topics: Adult; Angiography, Digital Subtraction; Cerebrovascular Circulation; Female; Humans; Infusions, Int | 2016 |
Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: Influence on clinical course and predictors of clinical outcome.
Topics: Female; Humans; Injections, Intra-Arterial; Male; Middle Aged; Nimodipine; Prognosis; Radiography; R | 2016 |
Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage?
Topics: Adult; Aged; Female; Humans; Infusions, Intra-Arterial; Intracranial Aneurysm; Male; Middle Aged; Ni | 2016 |
Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage.
Topics: Adult; Aged; Angioplasty, Balloon; Cerebral Arteries; Endovascular Procedures; Female; Humans; Injec | 2016 |
Retinal Vessel Analysis (RVA) in the Context of Subarachnoid Hemorrhage - A Proof of Concept Study.
Topics: Adult; Aged; Aneurysm; Brain Ischemia; Case-Control Studies; Cerebrovascular Circulation; Female; Hu | 2016 |
Comparison of the Effects and Mechanism of the Curcumin with Different Drugs in Experimental Vasospasm After Subarachnoid Hemorrhage.
Topics: Animals; Apoptosis; Basilar Artery; Cerebellum; Cerebral Cortex; Curcumin; Interleukin-1beta; Interl | 2017 |
Reversible Cerebral Vasoconstriction Syndrome.
Topics: Adult; Brain Infarction; Circle of Willis; Coronary Vasospasm; Female; Headache Disorders, Primary; | 2016 |
Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
Topics: Cerebral Angiography; Chronic Disease; Disease Progression; Echoencephalography; Female; Humans; Inf | 2017 |
Chemical angioplasty with spasmolytics for vasospasm after subarachnoid hemorrhage.
Topics: Adult; Angioplasty; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nimodipine; Subara | 2017 |
Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
Topics: Adult; Aged; Cerebrovascular Circulation; Female; Homeostasis; Humans; Infusions, Intra-Arterial; In | 2017 |
Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery Whil
Topics: Delayed-Action Preparations; Humans; Maximum Tolerated Dose; Nimodipine; Subarachnoid Hemorrhage; Va | 2017 |
Response by Hänggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles
Topics: Delayed-Action Preparations; Humans; Maximum Tolerated Dose; Nimodipine; Subarachnoid Hemorrhage; Va | 2017 |
Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
Topics: Adult; Angiography, Digital Subtraction; Calcium Channel Blockers; Cerebral Angiography; Cerebral In | 2008 |
Nimodipine: test your drug IQ.
Topics: Adult; Calcium Channel Blockers; Drug Interactions; Humans; Nimodipine; Patient Education as Topic; | 2008 |
Intra-arterial nimodipine to treat symptomatic cerebral vasospasm following traumatic subarachnoid haemorrhage. Technical case report.
Topics: Brain Infarction; Cerebral Angiography; Cerebral Arteries; Head Injuries, Closed; Humans; Injections | 2008 |
Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
Topics: Administration, Topical; Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Blockers; Dis | 2009 |
Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine.
Topics: Brain; Cerebral Angiography; Female; Headache Disorders, Primary; Humans; Hyperlipidemias; Hypertens | 2009 |
Prostacyclin treatment normalises the MCA flow velocity in nimodipine-resistant cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Cerebral Arteries; Cerebrovascular Circula | 2009 |
Headache and visual symptoms in two patients with MRI alterations in posterior cerebral artery territory.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Clopidogrel; Diagnosis, Differential; Diffusion Magnetic | 2009 |
Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model.
Topics: Animals; Antihypertensive Agents; Cerebral Angiography; Dose-Response Relationship, Drug; Drug Conta | 2009 |
Effects of topical administration of nimodipine on cerebral blood flow following subarachnoid hemorrhage in pigs.
Topics: Administration, Topical; Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Male; | 2013 |
[Effects of human urinary tissue kallikreins on vasodilation of basilar artery in rabbits with symptomatic cerebral vasospasm].
Topics: Animals; Disease Models, Animal; Female; Humans; Male; Nimodipine; Rabbits; Random Allocation; Tissu | 2009 |
The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model.
Topics: Animals; Basilar Artery; Cilostazol; Disease Models, Animal; Drug Therapy, Combination; Injections, | 2009 |
Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm.
Topics: Adult; Anticoagulants; Calcium Channel Blockers; Cerebral Angiography; Drug Therapy, Combination; Em | 2010 |
Cerebral malaria: a vasculopathy.
Topics: Animals; Artemether; Artemisinins; Humans; Malaria, Cerebral; Mice; Nimodipine; Plasmodium berghei; | 2010 |
Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.
Topics: Animals; Artemether; Artemisinins; Arterioles; Body Temperature; Cell Adhesion; Cerebrovascular Circ | 2010 |
Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats.
Topics: Analysis of Variance; Animals; Antioxidants; Azoles; Brain; Drug Administration Schedule; Female; In | 2010 |
Acute vasospasm following transcallosal resection of a xanthogranulomatous colloid cyst of the 3rd ventricle.
Topics: Angioplasty; Calcium Channel Blockers; Central Nervous System Cysts; Cerebral Angiography; Cerebral | 2010 |
Packed red blood cell age does not impact adverse events or outcomes after subarachnoid haemorrhage.
Topics: Adult; Aged; Blood Preservation; Cerebral Infarction; Coma; Erythrocyte Aging; Erythrocyte Transfusi | 2011 |
Comparison of nimodipine delivery routes in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.
Topics: Administration, Oral; Analysis of Variance; Angiography, Digital Subtraction; Animals; Basilar Arter | 2011 |
Comparison of intrathecal dotarizine and nimodipine treatments in cerebral vasospasm after subarachnoid hemorrhage: an experimental study in rabbits.
Topics: Angiography, Digital Subtraction; Animals; Basilar Artery; Benzhydryl Compounds; Calcium Channel Blo | 2011 |
Comparison of intrathecal flunarizine and nimodipine treatments in cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits.
Topics: Angiography, Digital Subtraction; Animals; Basilar Artery; Calcium Channel Blockers; Disease Models, | 2011 |
The effects of intrathecal nicergoline and nimodipine in cerebral vasospasm: an experimental study in rabbits.
Topics: Adrenergic alpha-Antagonists; Angiography, Digital Subtraction; Animals; Basilar Artery; Calcium Cha | 2011 |
[Changes of nitric oxide and endothelin-1 levels in rat brain tissue during cerebral vasospasm following subarachnoid hemorrhage and protective effect of nimodipine].
Topics: Animals; Brain; Cerebrovascular Circulation; Disease Models, Animal; Endothelin-1; Nimodipine; Nitri | 2001 |
Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases?
Topics: Adult; Angiography, Digital Subtraction; Diagnosis, Differential; Female; Humans; Image Interpretati | 2011 |
Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
Topics: Adult; Cerebral Angiography; Cerebrovascular Circulation; Female; Humans; Infusions, Intra-Arterial; | 2011 |
Activation of vascular KCNQ (Kv7) potassium channels reverses spasmogen-induced constrictor responses in rat basilar artery.
Topics: Animals; Basilar Artery; Celecoxib; Electrophysiology; Gene Expression Regulation; KCNQ Potassium Ch | 2011 |
[Effects of nimodipine on rabbits with symptomatic cerebral vasospasm].
Topics: Animals; Basilar Artery; Disease Models, Animal; Nimodipine; Rabbits; Vasodilator Agents; Vasospasm, | 2011 |
Letter to the editor re Mani et al.
Topics: Animals; Celecoxib; KCNQ Potassium Channels; Male; Nimodipine; Pyrazoles; Sulfonamides; Vasoconstric | 2011 |
Endovascular treatment of severe vasospasm in nonaneurysmal perimesencephalic subarachnoid hemorrhage.
Topics: Adult; Angiography, Digital Subtraction; Angioplasty, Balloon; Blood Flow Velocity; Calcium Channel | 2011 |
Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion.
Topics: Calcium Channel Blockers; Cerebral Angiography; Humans; Infusions, Intra-Arterial; Nimodipine; Retro | 2011 |
Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Topics: Adult; Calcium Channel Blockers; Cerebral Angiography; Female; Follow-Up Studies; Humans; Infusions, | 2011 |
Thunderclap headache triggered by micturition: responsive to nimodipine.
Topics: Antihypertensive Agents; Female; Headache Disorders, Primary; Humans; Hypertension; Middle Aged; Nim | 2011 |
Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Brain Ischemia; Capillaries; Carotid Artery, I | 2012 |
Puerpera with dyspnoea and epileptic seizure.
Topics: Adult; Calcium Channel Blockers; Cerebrovascular Disorders; Coronary Angiography; Dyspnea; Epilepsy; | 2013 |
Cisternal sustained release dihydropyridines for subarachnoid hemorrhage.
Topics: Animals; Delayed-Action Preparations; Dihydropyridines; Disease Models, Animal; Dogs; Female; Macaca | 2012 |
Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats.
Topics: Animals; Blood-Brain Barrier; Cerebrovascular Circulation; Cisterna Magna; Disease Models, Animal; M | 2012 |
Dose-response relationship of locally applied nimodipine in an ex vivo model of cerebral vasospasm.
Topics: Animals; Cerebral Arteries; Dose-Response Relationship, Drug; Male; Nimodipine; Rats; Rats, Wistar; | 2013 |
Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Topics: Adult; Angiography, Digital Subtraction; Angioplasty, Balloon; Chi-Square Distribution; Female; Huma | 2012 |
Reversible cerebral vasoconstriction syndrome: treatment with multiple sessions of intra-arterial nimodipine and angioplasty.
Topics: Angioplasty, Balloon; Cerebral Angiography; Combined Modality Therapy; Diagnosis, Differential; Fema | 2012 |
Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage.
Topics: Angiography, Digital Subtraction; Animals; Brain; Calcium-Binding Proteins; Delayed-Action Preparati | 2012 |
Acupuncture for cerebral vasospasm after subarachnoid hemorrhage: a retrospective case-control study.
Topics: Acupuncture Therapy; Adult; Aged; Aneurysm, Ruptured; Case-Control Studies; Cerebral Angiography; Co | 2013 |
Surgical treatment of ruptured anterior circulation aneurysms: comparison of pterional and supraorbital keyhole approaches.
Topics: Anesthesia, General; Aneurysm, Ruptured; Calcium Channel Blockers; Female; Glasgow Outcome Scale; Hu | 2013 |
In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm.
Topics: Delayed-Action Preparations; Microspheres; Nimodipine; Subarachnoid Hemorrhage; Treatment Outcome; V | 2013 |
Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option?
Topics: Calcium Channel Blockers; Cerebral Angiography; Constriction, Pathologic; Female; Humans; Magnetic R | 2003 |
Bathing headache: a variant of idiopathic thunderclap headache.
Topics: Adult; Baths; Brain Infarction; Cerebellar Diseases; Cerebellum; Cerebral Arteries; Female; Headache | 2003 |
[Cerebral vasospasms with hemodynamic infarctions as a complication of HELLP syndrome].
Topics: Adult; Cesarean Section; Diagnostic Imaging; Dose-Response Relationship, Drug; Female; Follow-Up Stu | 2003 |
The pharmacologic treatment of vasospasm after subarachnoid hemorrhage: a case study.
Topics: Adult; Blood Pressure; Brain; Cardiotonic Agents; Dobutamine; Female; Fluid Therapy; Hemodilution; H | 2003 |
Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage.
Topics: Adult; Aged; Blood Pressure; Cerebral Angiography; Female; Heart Rate; Humans; Infusions, Intra-Arte | 2005 |
Clinical experience of selective intra-arterial nimodipine treatment for cerebral vasospasm following subarachnoid hemorrhage.
Topics: Calcium Channel Blockers; Humans; Infusions, Intra-Arterial; Nimodipine; Subarachnoid Hemorrhage; Va | 2006 |
Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm.
Topics: Angiography; Animals; Cerebrovascular Circulation; Nimodipine; Rabbits; Subarachnoid Hemorrhage; Tom | 2006 |
[Idiopathic thunderclap headache: reversible vasospasm of the Arteria basilaris].
Topics: Adult; Angiography, Digital Subtraction; Cerebral Angiography; Diagnosis, Differential; Headache Dis | 2006 |
Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage.
Topics: Animals; Antihypertensive Agents; Apolipoproteins E; Behavior, Animal; Calcium Channel Blockers; Dis | 2006 |
Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Topics: Adult; Aged; Brain Ischemia; Calcium Channel Blockers; Cerebral Angiography; Cerebral Infarction; Fe | 2006 |
Symptomatic intracranial stenosis: cerebrovascular complications from elective stent placement.
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon; Cerebral Hemorrhage; Female; Humans; Intracranial Art | 2007 |
Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Topics: Calcium Channel Blockers; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Act | 2007 |
[Systemic treatments of the vasospasm].
Topics: Hemodilution; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hy | 2007 |
[Endovascular treatment of vasospasm following subarachnoid aneurysmal haemorrhage].
Topics: Calcium Channel Blockers; Humans; Intracranial Aneurysm; Nicardipine; Nimodipine; Nitroprusside; Pap | 2007 |
Continuous intra-arterial infusion of nimodipine during embolization of cerebral aneurysms associated with vasospasm.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Embolization, Therapeutic; Female; Humans; Infusions, Intra-Art | 2008 |
Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo.
Topics: Animals; Basilar Artery; Cerebral Angiography; Female; Injections, Spinal; Male; Nimodipine; Nitric | 2008 |
Can changes in BIS provide clue to lower limit of cerebral autoregulation?
Topics: Adrenergic alpha-Agonists; Anesthesia, General; Antihypertensive Agents; Blood Pressure; Cerebrovasc | 2008 |
Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience.
Topics: Algorithms; Angioplasty, Balloon; Calcium Channel Blockers; Catheterization; Cerebral Angiography; D | 2001 |